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Abstract 
 
Current drug therapies have lost their effectiveness in controlling the fungal species 
known as C. albicans; therefore, the need for newer drugs becomes crucial. Histatin 5 
(Hst 5), a naturally occurring peptide found in the oral cavity, has demonstrated strong 
effects on controlling candidiasis. Here, we have proposed that the adhesion of cells 
through surface proteins is an important process. To allow the analysis of surface 
proteins, the concept of on-whole cell tryptic digestions were developed. This on-target 
approach allows for isolation of the peptides of interest, while greatly reducing digestion 
times.  
To study the effects of Histatin 5 on surface proteins, live cells were adhered to slides 
pre-coated with human serum albumin (HSA); and subsequently, treatments with Hst 5 
were done. Mass spectrometry was used to correlate changes in ion counts to protein 
expressions. Preliminary work done by MALDI MS verified that changes in ion counts 
occurred, as well as tentative protein identifications. Then, HPLC-ES-MS/MS was used 
to verify proteins and their biological processes. A few proteins were seen from the cell 
surface, where their presences indicated the success of our on-target approach. Three 
other processes were found; virulence, mitochondrial associated and nucleic acid binding. 
Hst 5 was shown to decrease the expression of proteins involved in the virulence, 
supporting Hst 5 as an antifungal agent. The identified proteins involved in the last two 
pathways have provided additional support for the speculation that cellular respiration in 
the mitochondria may be the true target of Hst 5. 
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Section 1   Introduction 
 
1.1   Mass Spectrometry (MS) of Microorganisms  
 
1.1.1   Protein Profiling for Taxonomy 
 
The ability to differentiate microbial species can be beneficial, as it allows for rapid 
clinical identification of pathogenic and non-pathogenic species. Traditional 
identification methods are based on morphology and biochemistry. Unfortunately, this 
led to sample preparations spanning several days, which can hinder clinical applications. 
As such, identification using the genome sequence is now the standard. Indeed the 
genome does provide the most accurate identification; however, analysis of the genome is 
time-consuming and challenging. The analysis of proteins has been recognized as a post-
genomic science, allowing one to indirectly study the genome. Therefore, protein analysis 
performed by mass spectrometry (MS) is an excellent alternative for microbial speciation. 
Two “soft” ionization techniques, electrospray ionization (ESI) and matrix-assisted laser 
desorption ionization (MALDI), allow for protein analyses. The detailed mechanisms of 
both ionization techniques coupled with MS are discussed in Appendix 1.  
In microbiology, MS offers significantly simplified sample preparations, a high degree of 
certainty, and more importantly, rapid analyses of proteins. MS has been shown to 
effectively determine taxonomy down to the genus, species and strain levels [1]. In this 
approach, the process of profiling either the complete proteome or a sub-fraction of 
proteins, are used for identification. This can be achieved by developing key mass-to-
charge (m/z) signals, known as biomarkers, which are characteristic to specific 
microorganisms. These biomarkers are like the microorganism’s fingerprint, and so by 
incorporating them into a database, rapid identification is possible [2]. 
In 1998, Liu et al. successfully used this biomarker method for the identification 
Escherichia coli from crude lysates [3]. In their work, cells were lysed open and the 
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resulting lysate was analyzed via MS. Due to the complexity of using cell lysates, 
separation techniques like liquid chromatography (LC) are often used, therefore making 
ESI MS more favourable. In Liu’s work, however, they developed their own cellulose-
based molecular weight cut off microdialyzer for fractionation. Their work demonstrated 
the need for a sample cleanup prior to mass spectral analyses. Despite this success, more 
rapid methods are sought after as LC-ESI-MS has a lower sample throughput and is still 
time-consuming.  
MALDI MS offers several advantages with regards to biomarker fingerprinting. The 
main improvement is the rate of data acquisition. In MALDI MS, larger amounts of data 
can be analyzed over a set period of time. This is because many samples can be spotted 
onto a single plate. Protein profiling for microorganisms using MALDI MS was first 
introduced by Cain et al. in 1994 [4]. In their work, cells from the Pseudomonas species 
were lysed using sonication, and the released proteins were analyzed. By comparing 
spectra obtained from pure bacterial cells to those obtained from mixtures, they 
developed biomarkers characteristic to each species. As a result, these biomarkers were 
able to accurately identify the Pseudomonas species within mixtures.  
Despite these successes, there was still one drawback in MS of microorganism speciation. 
This would be the use of crude lysates. Lysates are biologically complex and almost 
always require a sample cleanup to help improve detection. Because of this, methods 
using whole intact cells, rather than lysates, became of interest. Anhalt and Fenselau were 
able to use whole microbial cells for biomarker identification [5].
 
In their work, cells 
from several bacterial species were directly inserted into the ion source of a pyrolysis 
mass spectrometer. The gentle heating of the cells lead to partial vaporization, and the 
resulting spectra were able to differentiate the species. Their success demonstrated that 
using whole cells directly, instead of cellular fractions, was possible with the same 
results.  
With whole cells, both the use of ESI and MALDI, have been explored. Vaidyanathan et 
al. reported using ESI MS by injecting suspensions of whole cells directly into the mass 
spectrometer [6]. In addition, they were able to identify strains of bacteria without the use 
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of LC. Unfortunately, for ESI MS clogging by the intact cells may occur. And yet again, 
sample throughput is still limited due to rinsing and sample loading steps. Because of 
this, MALDI MS seemed more as a suitable candidate for whole cell analyses. 
With MALDI MS, intact cell sample handing and analyses become simpler. In general 
the procedure for these analyses can be completed in three steps [7]. To start, fresh cells 
of a colony are transferred from the media plate to the MALDI target. Samples are then 
overlaid with a matrix, where α-cyano-4-hydroxycinnamic acid (CHCA) and sinapinic 
acid (SA) were proven to produce better signals [8, 9]. And lastly, once dried, they can be 
introduced into the mass spectrometer. Holland et al. successfully carried out this 
described procedure towards identifying five bacterial strains in a mixture [8]. With cells 
only needing to be transferred directly to the MALDI target, the application of MALDI 
for microorganisms is limitless. It does not encounter needle clogging and MALDI MS is 
more tolerant to higher salt concentrations. Together, MALDI MS seems to be more 
appropriate in whole cell analysis.  
 
1.1.2   Surface Proteins and Enzymatic Cleavages 
Out of all proteins encoded by the genome, interest has shifted towards investigating the 
surface proteome. The surface proteome encompasses all proteins present at the cell 
surface under a specific condition and time [10].
 
These proteins localize to the 
cytoplasmic membrane, membrane-cell wall interface or the cell wall [11]. There they 
may be partially or completely exposed to the external environment. This meant that they 
can be freely soluble, held within vesicles or surface-attached [12]. Surface proteins have 
multiple functions that are vital to cell survival which include; transportation of nutrients, 
acting as receptors for signalling pathways, acting as binding factors to other cells and 
surfaces, and lastly, they have enzymatic activities [12]. 
Within microbiology, surface proteins are of particular importance as they play crucial 
roles in establishing pathogenesis. The first step in causing an infection is to adhere to 
host epithelial tissues [13]. Once attached, they can grow and ultimately invade the host 
system [14]. Upon invasion, they can release toxins and cause serious health concerns. 
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Additionally, surface proteins allow for microorganisms to send appropriate signals to the 
cytoplasm for defense against toxins and host immune responses [15]. For the host, the 
first encounter is the surface proteome, and because of this, surface proteins may be 
important for future drug therapies. 
While the need for understanding surface proteins is crucial, not much is known about 
them. This is majorly due to difficulties in defining their protein compositions and 
surface topologies [14]. There are three methods that have been used for identifying 
surface proteins. The first method involves the use of algorithms with genome analysis to 
predict where surface proteins may be located [16]. This technique albeit rapid, was 
neither fully reliable nor quantitative. A second approach would be to isolate membrane 
and cell wall fractions from cytoplasmic ones [17]. Unfortunately, this suffered 
contamination from cytoplasmic proteins. And lastly, antibodies that bind surface 
proteins may be used [18]. In this method, surface proteins are predicted and tested 
against antibodies to see whether binding occurs. When binding occurs, then there is 
conformation of a surface protein.
 
This has been shown to be successful, however, it was 
very expensive and labour intensive. Overall, convenient methods are available for 
identifying surface proteins, but, to minimize complications, others should be 
investigated.  
It was not until 2006 where the concept of limited proteolysis was coupled with MALDI 
MS. In 2006, Rodriguez-Ortega et al. established a protocol for what was termed “cell 
shaving", where proteins partially exposed on the outside of bacterial cells were isolated 
[14]. In their protocol, live cells of group A Streptococcus were analyzed. Group A 
referred to the sub-classification for specific carbohydrates present on the cell wall of the 
β-hemolytic groups of microorganisms. β-hemolytic groups are those that completely 
rupture red blood cells in their pathogenesis. Cells of group A Streptococcus were 
subjected to the proteolytic enzymes, trypsin or proteinase K, to cleave peptides at the 
surface. The use of enzymes to "shave" the cell surface allows for peptides to be released 
into the surrounding buffer, allowing them for their separations from remaining cells. The 
peptide-buffer mixture was collected and then analyzed with MADLI-MS. In theory, 
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these digestions should only target regions protruding outside of cells, hence, the peptides 
can be said to belong to surface proteins.  
Although studies involving surface digestions center on the use of MALDI MS for 
analyses, it should be clarified that the use of ESI MS iwa possible. Phinney et al. used 
limited proteolysis to understand how proteins of the Sindbis virus are arranged on the 
cell surface [19]. It was determined that under different environmental conditions, 
different protein regions are exposed and can be readily digested using trypsin. The 
resulting peptides were released, separated by HPLC and then analyzed by ESI MS. In 
addition, the recent development by Randall et al. demonstrated analyses of surface 
digestions using ESI MS without a need for any separation [20]. They directly coupled 
on-target surface protein sampling with nano-ESI inlet needle for mass spectral analyses. 
 
1.2    Candida albicans (C. albicans) 
 
Through collaboration with Dr. Walter Siqueira in Dentistry at UWO, our research has 
become interested in studying microorganisms occupying the oral cavities and their 
associated salivary proteins. Further knowledge can allow for a long term goal of 
promoting oral health and defense against oral pathogens. From all of the 
microorganisms in the oral cavity, our focus is towards the fungal species Candida 
albicans (C. albicans), with its high increasing infection rates and ineffective oral 
therapeutic treatments.  
C. albicans can be found within the gastrointestinal and genitourinary tracts, as well as on 
the surface of skins [21]. It exists within humans in a commensal relationship, where it 
benefits without causing any damage. However, in individuals with compromised 
immune systems, C. albicans can cause dangerous infections known as candidosis [22]. 
This includes individuals with acquired immune deficiency syndrome (AIDS), transplant 
recipients, and those receiving chemotherapy [23]. There are two types of infections that 
may occur, superficial and systemic. Superficial infections affect the skin, hair, nails and 
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mucosal membranes [24]. Whereas systemic infections occur within major body organs 
such as the kidney, heart and brain [25]. 
C. albicans exists in three distinct morphological forms; the unicellular yeast, 
pseudohyphae with the starting growth of filaments, and as hyphae with fully grown 
filaments. All three forms can be observed under varying growth; below 30°C or at pH 
4.0, 30°C at pH 6.0., and 37°C at pH 7.0 or in N-acetylglucosamine, respectively.  It is 
because of this ability to adopt three forms, that C. albicans can be fatal. It enters the host 
as the budding yeast, growing into the hyphal state to penetrate tissues [21]. And it is 
only the hyphae that can initiate pathogenesis. As a result, the hyphal form carries the 
most resilience to current therapeutic treatments [26]. In addition to these three states, C. 
albicans can also form surface-attached communities called biofilms [21]. Biofilms are 
cell communities encased in a matrix of extracellular polymeric substances. They can be 
found on medical devices such as dentures, shunts, implants, peacemakers and catheters 
[27]. Once growth starts on them, C. albicans becomes extremely difficult to remove, 
where the only solution is to remove the device completely. 
The most common way to treat candidiasis is to administer oral antifungal drugs. Four 
categories of antifungal agents are available, classified according to their working 
mechanism. The first class aims to disrupt the cell membrane, which the drug 
amphotericin belongs [22]. The second group, including drugs like fluconazole, works to 
inhibit the synthesis of ergosterol for the cell membrane [28]. Ergosterol is a key 
component for maintaining cell membrane integrity. Third, is a group of drugs aimed 
towards inhibiting the synthesis of the cell wall polysaccharide known as β-1,3-glucan 
[22]. Lastly, is a group targeted towards the induction of incorrect ribonucleic acid 
(RNA) synthesis and deoxyribonucleic acid (DNA) replication [22]. Despite these 
different types, antifungal agents are losing their effectiveness in treatments. One 
significant problem with using antifungal agents is that C. albicans has developed 
resistance towards them [28]. In addition, the drug dose at the target site is not high 
enough to illicit a response [22]. One simple solution to these complications may be to 
develop additional drugs, however, this is challenging in itself. Fungal species are 
eukaryotic which means they share common biological process as humans [29]. The 
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development of new drugs must be done in such a way that no serious side effects occur 
in humans. Consequently, these drugs can cause serious side effects in humans. As such, 
newer approaches targeted towards controlling C. albicans are needed. 
 
1.3    Histatin 5 (Hst 5) 
 
For infections to start, adhesion to oral surfaces must occur where C. albicans can begin 
to colonize [30]. The process of adhesion is controlled by the development of an acquired 
pellicle. This acquired pellicle develops on surfaces composed of about 130 proteins, 
carbohydrates and lipids [31]. Of all the proteins, salivary proteins like histatins, statherin 
and acidic proline-rich ones are of interest as they exhibit antifungal properties [32].
 
Vukosavljevic et al. have suggested that a newer approach to control C. albicans can be 
done at the pellicle level by increasing the amount of these proteins [32].
 
One family of 
proteins, the histatins, are of particular interest.  
The histatin family differs from other proteins due to three factors; their unusually high 
histidine content, lack of disulfide bonds, and their weak amphipathic nature [33].
  
They 
are cationic peptides ranging in length from 7-38 amino acids [34]. These peptides are 
naturally found within the human body, being secreted from only the partoid and 
submandibular glands [35].  
Histatin peptides come in three forms; Histatin 1 (Hst 1), Histatin 3 (Hst 3) and Histatin 5 
(Hst 5), all containing 7 histidine residues, as shown above [35]. Hst 1 is composed of 50 
amino acids with a molecular weight of 4929 Da.
 
Hst 3 contains 51 amino acids with a 
mass of 4063 Da. And Hst 5, has 25 amino acids with the smallest mass at 3037 Da. Hst 
1 and 3 are derived from different structural genes, and Hst 5 is the proteolytic product of 
Hst 3. The amino acid sequences of all three histatins are shown in Figure 1.1. The 
effects of histatin peptides have been explored by Oppenheim et al., where they were 
shown to inhibit the conversion of C. albicans to its pathogenic form. [36]. As a 
consequence of this, Vukosavljevic et al. noticed the inability of cells to colonize denture 
materials [30].  
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Figure 1.1. The histatin family is comprised of three histidine-rich peptides; Hst 1, Hst 3 
and Hst 5. Hst 1 and Hst4 are derived from different structural genes, and Hst 5 is a 
proteolytic product of Hst 3. Histatin peptides are naturally-occurring, with synthesis and 
secretion from the parotid and submandibular glands. 
 
From this family, Hst 5 has gained attention due to its higher potency. Oppenheim 
discovered that using Hst 5, in comparison to the others, showed a 90-100% killing effect 
at physiological conditions [37]. Two general theories have been proposed; the first 
affects the cell membrane and the second, affects cellular respiration at the mitochondria. 
The first theory stems from the general mechanism of how antibiotics work. In 1996, Raj 
et al. discovered that antimicrobial agents work by adopting an amphipathic structure to 
allow their insertion into the cell membrane [38] However, structural analysis of Hst 5 
indicated it being weakly amphipathic [33]. Therefore, it cannot insert itself into the cell 
membrane. Others have suggested that if Hst 5 is not being inserted, then perhaps the cell 
membrane is being lysed instead [39]. Unfortunately, this concept was proven incorrect 
by Baer et al. [40]. 
The theory regarding Hst 5 and its effects on the mitochondria was first defined by 
Helmerhorst et al. [41]. They discovered that when Hst 5 was applied towards respiring 
and non-respiring cells, the non-respiring ones were unaffected. In addition, they showed 
that when Hst 5 is taken up by C. albicans, the peptides are localized towards the 
mitochondria. This may be due to the similarities between mitochondria pre-sequences 
and Hst 5. Recent work by Komatsu et al. further supplemented the effects of Hst 5 on 
the mitochondria [42]. By investigating the expression before and after Hst 5 treatments, 
changes in proteins involved in cellular respiration were observed.  The inhibition of the 
         Hst 3    MKFFVFALIL ALMLSMTGAD SHAKRHHGYK RKFHEKHHSH RGYRSNYLYD N 
   
Hst 5            DSHAKRHHGYKRKFHEKHHSHRGY 
Hst 1       MKFFVFALVL ALMISMISAD SHEKRHHGYR RKFHEKHHSH REFPFYGDYG 
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Krebs cycle and loss of adenosine triphosphate (ATP) from cells lead to cell death. 
Overall, this does provide further insight towards how Hst 5 works. However, the exact 
mechanistic nature of Hst 5 on C. albicans remains unclear. The whole process is thought 
to possess multiple steps with many missing links and uncertainties. 
 
1.4   Thesis Overview 
 
MS for studying microorganisms has been gaining attention. The identification of 
proteins expressed by these microbes is a newer approach into developing new 
therapeutics against them. The fungal species, C. albicans, has become increasingly 
effective in combating current oral antifungal agents. As a result, infection rates have 
reached high numbers. One factor potentially contributing to its virulence is in its ability 
to adhere to host surfaces. Once adhered, cells can easily colonize and penetrate tissues 
for pathogenesis. With adhesion being the initial encounter between host and fungus, one 
theory of how Hst 5 works can be hypothesized. Hst 5 may be altering the expression of 
surface proteins, causing cells to no longer have the ability to adhere. Previous proteomic 
work has been done by the Siqueira Lab. They have grown cells of C. albicans with Hst 
5, and performed in-solution tryptic digestions resulting in the lysis of cells. Analyses of 
the lysates were performed using HPLC-ESI-MS and database searches; however, the 
quantity of resulting peptides was extensive. This made it challenging to identify key 
proteins that may have any relevance.  
Recent work accomplished by Moffa et al. in the Siqueira Lab has shown that upon 
introducing Hst 5 within ninety minutes of cell adhesion, the number of cells remaining 
has decreased [43]. Concurrently, they observed the inhibition of C. albicans into the 
hyphal form in the presence of Hst 5. The precise cause of the decrease in adhesion has 
yet to be explained; however, here we hypothesize the influence of Hst 5 on surface 
proteins. By working concurrently with the Siqueira Lab, we can develop sample 
preparations to mimic the adhesion process in the oral cavity. Then by performing 
digestions on whole cells, we can reduce the sample pool and specifically isolate surface 
proteins.  Overall, this research will specifically address the following: 
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a. The development of on-cell digestions for direct performance on C. albicans. 
b. The adhesion of C. albicans to a solid support followed by treatment with the 
Hst 5 peptide  
c. Analyses by MS to detect changes in the expression of the identified proteins 
following treatment.  
Our results may help to identify key surface proteins and their roles in particular 
biological pathways. Our combined results may supplement the understanding of Hst 5 
and its influence on C. albicans. Furthermore, our developed surface digestion approach 
may have potential applications towards understanding the pathogeneses of other 
microorganisms. 
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Section 2   Experimental 
 
2.1   Reagents 
 
Deionized water (18.2 Ω grade) was used for all experiments. Purification was done by 
the Milli-Q Gradient A10 System (Millipore, USA).  
A 0.1 mg/mL solution of human serum albumin (HSA) was used for cell adhesion 
(Sigma Aldrich, USA). Frosted 76 x 26 mm glass microscope slides (VWR, Canada) 
were used as the solid support for adhesion. Stock cultures of C. albicans in glycerol 
were provided by the Siquiera Lab from Dentistry at University of Western Ontario. The 
strain provided was ATCC90028. BD Difco Sabouraud dextrose agar (SDA) medium 
(Becton Dickson and Company, USA) was used as the agar base for cultivating fungal 
microorganisms. The growth of cells in solution was done using the media called yeast 
nitrogen base (YNB) broth (Sigma Aldrich, USA) supplemented with sucrose (BioShop 
Canada Inc, Canada). The media was sterilized and filtered using a BD 10 mL syringe 
(Becton Dickson and Company, USA) through 25 mm IC Acrodisc syringe filters with a 
0.45 µm Supor (PES) membrane (PALL Corporation, USA). 1X phosphate buffer 
solution (PBS) was used in between for washings (Sigma Aldrich, USA). Histatin 5 
(China Peptides Co., China) peptides were also provided by the Siquiera Lab.  
Tosyl phenylalanyl chloromethyl ketone (TPCK)-treated trypsin from bovine pancreas 
(Sigma Aldrich, USA) was used for all digestions. To activate digestions, trypsin was 
resuspended in 50 mM ammonium bicarbonate at pH 8 (Sigma Aldrich, USA). Two 
standard proteins, horse heart cytochrome c (Sigma Aldrich, USA) and horse heart 
myoglobin (Sigma Aldrich, USA), were used for the development of on-target digestions. 
During incubations and digestions, the Dako delimiting pen composed of 60-100% 1-
bromopropane and 5-10% dipentene (Cedarlane, Canada) was used to draw hydrophobic 
circles.  
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For MALDI MS analyses, peptides were mixed in a 1:1 (v/v) ratio with 5.5 mg/mL α-
cyano-4-hydroxycinnamic acid (CHCA) matrix solution containing 6 mM ammonium 
phosphate monobasic, 50% acetonitrile and 0.1% trifluoroacetic acid (Sigma Aldrich, 
USA).  
Bovine serum albumin (BSA) was used as the standard for the bicinchoninic acid (BCA) 
assays (Sigma Aldrich, USA). The Pierce BCA protein assay kit (Life Technologies, 
USA) was used for peptide quantification. Both standards and the peptides were mixed 
with the BCA reagent in a 96-well polystyrene microplate (Life Technologies, USA).  
Before injection into the HPLC-ESI mass spectrometer, peptides underwent sample 
cleanup via ZipTip (Millipore, USA). There were four solutions used during this 
procedure. 50% acetonitrile (Sigma Aldrich, USA) was used to decontaminate the C18 
column. 0.1% trifluoroacetic acid (Sigma Aldrich, USA) was then used to remove excess 
acetonitrile. 0.5% trifluoroacetic acid was added to acidify peptides to allow binding to 
the negatively-charged column. And lastly, a solution of 80% acetonitrile (Sigma 
Aldrich, USA) was used to elude peptides off the column. After drying, peptides were 
resuspended in 0.1% formic acid (Sigma Aldrich, USA). Solvent B (Sigma Aldrich, 
USA), composed of 97.5% acetonitrile and 0.1% formic acid, was used in HPLC.  
 
2.2  Instrumentation 
 
2.2.1   MALDI MS 
 
Samples were mixed in a 1:1 (v/v) ratio with 5.5 mg/mL CHCA matrix solutions prior to 
analyses. All sample-matrix mixtures were spotted on a 384 well Opti-Tof 123x83 mm 
SS MALDI plate (AB Sciex, MA, USA). The instrument is equipped with a 349 nm 
OptiBeam On-Axis laser with a pulse rate at 400 Hz. Data acquisitions and processings 
were done using TOF TOF Series Explorer and Data Explorer. The spectra were acquired 
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in Reflectron positive mode, in the m/z range of 500-3500. Peak lists were created using 
the following parameters; a peak density of 10 per 25 Da, minimal signal-to-noise (S/N) 
of 10, minimum area of 50 and a maximum peak per spot of 200. Second fragmentation, 
MS/MS, was also performed via post-source decay (PSD) using the 1 kV Positive 
acquisition mode.   
2.2.2  HPLC-ESI-MS/MS 
 
The drying of peptides and analysis by HPLC-ESI-MS/MS were completed by the 
Siqueira Lab. This setup allows for online liquid chromatography to be coupled with 
direct introduction to the mass spectrometer for analyses. 
Prior to mass spectral analyses, peptides underwent sample cleanup using C18 ZipTip 
pipette tip columns. For the detailed protocol, please refer to Appendix 4. The eluted 
peptides then drying to remove solvents and concentrate the peptides. This was 
accomplished with the Vacufuge vacuum concentrator (Eppendorf, Germany). The 
drying of peptides was done at ambient room temperature for 10 minutes at 14000 rpm. 
Once dried, the peptides were resuspended in 0.1% formic acid.  
HPLC was carried out on the Thermo Scientific Easy nLC II instrument (Thermo 
Scientific, CA, USA). The 85 minute gradient composition ranged from 5 to 55% of 
solvent B. The flow rate used was 200 nL/min at a pressure of 280 bar. The volume of 
sample injected was 8 µL. Electrospray ionization was completed using a voltage of 2.0 
kV with an ion transfer capillary temperature of 250.00°C.  
Mass spectral analyses were performed on the Thermo Scientific linear trap quadrupole 
(LTQ) Velos ion mass spectrometer (Thermo Scientific, USA). Positive-mode data 
acquisitions and processing were done using Thermo Xcalibur 2.1.0 SP1.1162 software 
(Thermo Scientific, USA). The MS scan range used was 0-2000 m/z. MS/MS was done 
via collision induced dissociation (CID) using helium (He) as the inert gas. 
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2.3   C. albicans Growth and Cell Culturing 
 
Stock cultures of Candida albicans were provided by the Siqueira Lab from Dentistry at 
The University of Western Ontario. The strain of cells used throughout all experiments 
was ATCC90028. Prior to cell growth, SDA prepared plates were placed into a 37°C 
oven overnight to ensure the absence of other microorganisms. The exact protocol for 
preparing SDA plates is described in Appendix 2.  
To start growth, cell colonies were grown on the plate containing the SDA medium. 
Without thawing, a pipette tip of stock C. albicans was inoculated on the SDA plate. The 
inoculated plate was incubated in a 37°C oven for 48 hours. Figure 2.1 is the resulting 
colonies grown on the SDA plate.  
 
 
 
 
 
 
 
 
 
Figure 2.1 C. albicans budding yeast colonies grown on SDA plates. Each dot 
 corresponds to a single colony. 
 
One-third of a loop of the colonies on the SDA plate was transferred into about 45 mL of 
YNB100. The protocol for preparing YNB100 is described in Appendix 2.  The cells 
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were then incubated at 37°C for 21 hours with shaking at 200 rpm. After this incubation, 
optical density (OD) measurements were taken at 600 nm, giving what is known as OD-
600. OD600 correlates the amount of cells present in the solution to the level of light 
absorption. For C. albicans, the OD reading should be around 0.300. The measurements 
were performed on the NanoDrop 2000C spectrophotometer (Thermo Fisher Scientific 
Inc, USA). Following 21 hours, the solution was centrifuged (Avanti J-251 Centrifuge, 
Beckman Coutler, USA) for 5 minutes at 6000 rpm. The pellet was then resuspended in 
1X PBS, and the final C. albicans solution was stored at 4°C for no longer than one 
week.  For the cell lysate, the solution was centrifuged at 13 000 rpm for 5 minutes 
instead. The supernatant was collected and analyzed by MALDI MS.  
 
2.4   Adhesion of C. albicans to Glass Slides 
 
The protocol for cell adhesion onto a solid support was adapted from Vukosavljevic et 
al.[30]. In all adhesion experiments, glass slides were used as the platform in which cells 
were adhered. The setup for the incubations is shown in Figure 2.2. Here inverted glass 
vials containing wet cotton was used to cover the spots and retain humidity. vials 
containing wet cotton was used to cover the spots and retain humidity. A maximum of 
three spots per slide was used to prevent overcrowding of the vials. The Dako delimiting 
pen was used to draw hydrophobic circles (shown in blue), therefore minimizing 
spreading. The digestions were contained within hydrophobic circles of an inner diameter 
of 0.60 mm. The volume of HSA, C. albicans and Hst 5 used was 25 µL. All incubations 
were carried out on the bench top at ambient room temperature (RT).  
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Figure 2.2. The setup for the preparation of slides. The attachment of cells, treatment 
with Hst 5 and on-target digestions were carried out within the hydrophobic circle. The 
spots were covered with an inverted vial, where soaked cotton was used to retain 
moisture. A maximum of three spots per slide was used.  
 
In order for the cells of C. albicans to adhere, a pre-existing layer of HSA was needed. 
Before introducing solutions, the hydrophobic circles were drawn on the bare glass slide 
first. To each circle, 25 µL of 0.1 mg/mL HSA was added and the spots were covered 
with the vials. HSA incubation was done for 2 hours at RT. Once done, the spots were 
washed three times with water. To verify that cells of C. albicans did attach, microscope 
images of the slides were taken. Images were taken using the Leica DME basic 
microscope with the imaging component DFC295 (Leica Microsystems, Canada).Upon 
confirmation, Hst 5 was introduced next for the treatment. 
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2.5   Treatment of Hst 5 on Adhered Cells 
 
Two application methods of Hst 5 were investigated, pre-application and post-
application. The concentration of Hst 5 was 0.030 mg/mL, as suggested by the Siqueira 
Lab. In the pre-application method, as shown in Figure 2.3C, Hst 5 was introduced prior 
to adhesion of C. albicans. The HSA-coated slide was prepared as discussed above. Hst 5 
was added for incubation next. This was carried out at RT for 2 hours. Afterwards, the 
spots were washed thrice with 1X PBS. Last, 25 µL of the prepared C. albicans solution  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3. Schematic for the preparation of C. albicans adhered slides. Red represents 
HSA, green for C. albicans, and blue for Hst 5. (A), the control used was a HSA-C. 
albicans slide. In (B), the post-application slide of HSA-C. albicans-Hst 5 is prepared. 
And lastly in (C), is the pre-application slide of HSA-Hst 5-C. albicans. 
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was introduced. The incubation was performed for 90 minutes at RT. Again, once 
completed the spots were washed thrice with 1X PBS. This completed the attachment and 
treatment, where on-target digestions were performed afterwards. This will be discussed 
later. 
 
For the post-application method, HSA was first added as already discussed. Following 
this, 25 µL of the C. albicans solution was introduced next. The incubation was done for 
90 minutes at RT. Washing of the spots were done three times with 1X PBS. And lastly, 
25 µL  of 0.030 mg/mL Hst 5 was applied for a 2 hour incubation at RT. The spots were 
washed thrice before on-target digestions were performed. The preparation of the spots in 
post-treatments are shown in Figure 2.3B.  
Lower concentrations of Hst 5 used were also tested to determine the lowest threshold 
that could be used. Two lower concentrations, 0.025 and 0.020 mg/mL, were considered 
using both application methods. Glass slides were prepared according to Figure 2.3, and 
the varying concentrations of Hst 5 were introduced in place of the 0.030 mg/mL dose. 
Once prepared, the slides underwent on-target tryptic digests and peptides were collected 
for MALDI MS analyses.  
 
2.6   Tryptic Digestions 
 
2.6.1   Standard Overnight Digestions for Test Proteins 
 
Standard in-solution tryptic digestions were carried out prior to on-target digests. These 
served as the basis for comparison of the developed on-target digestions. Two proteins, 
cytochrome c and myoglobin, were chosen as the standard proteins. A ratio of 1:50 
enzyme-to-protein (v/v) was used. The concentration of trypsin was 1.0 mg/mL in 50 
mM ammonium bicarbonate with a pH of 8. Ammonium bicarbonate was incorporated 
for the activation of trypsin. The concentration of proteins used for digestions was 1.0 
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mg/mL in water. Once the standard proteins and trypsin were mixed together, the 
resulting solution was placed in a 37°C oven for an overnight digestion. The peptides 
were then lyophilized overnight and resuspended in water to a final concentration of 0.1 
mg/mL. This peptide solution was mixed with CHCA for MALDI MS analyses. 
 
2.6.2   Development of On-Target Tryptic Digestions 
It should be noted that when the term “on-target” was used, it referred to performing the 
digestions directly on the analyte. On-target digestions were developed as a substitution 
to the standard overnight protocols. To start, they were first performed using the standard 
proteins. These digestions were done on the MALDI plate on the bench top at room 
temperature. They were initially designed using the standard proteins, cytochrome c and 
myoglobin. 0.36 µL of 0.1 mg/mL standard protein was spotted onto the MALDI plate, 
whereby, 0.36 µL of 1.0 mg/mL trypsin was layered on top for digestions. The digestions 
occurred at ambient room temperature for ten minutes. Once completed, CHCA matrix 
was laid over top and mass spectral analyses were performed. The digestion time was 
also investigated to determine the optimal duration. To start, digestion times ranging 
from; 15, 30 and 45 seconds; and 1, 2, 3, 4, 5, 10, 15, 20, 25, 30 and 60 minutes, were 
explored on three replicates.  
With success from the standard proteins, the on-target surface digestions were applied 
towards the prepared C. albicans slides from Figure 2.3. Tryptic digestions with the 
following conditions were used; a concentration for trypsin of 0.0015 mg/mL and a 
digestion time of 10 minutes at RT. Again, during the digestions the spots were covered 
with the glass vials. Once digestion was completed, the peptide-containing buffer was 
recollected for mass spectral analyses. 
The conditions described above represented the optimal experimental factors. Prior to 
this, four experimental conditions were optimized. The first was to ensure the on-target 
digest was not lysing the cell to produce unwanted background noise. To do so, a cell 
lysate was prepared for comparison. Here, instead of centrifuging cells at a speed of 6000 
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rpm, they were spun at 13000 rpm. This faster speed would cause cell lysis. The 
supernatant was then collected for analyses. Next, five replicates of four final 
concentrations of trypsin were tested; 0.0005, 0.0075, 0.001, 0.0015 and 0.002 mg/mL.  
Lastly, the digestion time was re-evaluated for C. albicans. Here, digestion times of 5, 10, 
15 and 20 minutes were investigated. Three replicates were performed for each.  
In the case of MALDI MS, Fenselau reported that organic solvents can cause lysis which 
would incorporate signals from internal cellular components [44].  Here, the cells were in 
contact with three organic solvents from CHCA matrix. They were ammonium phosphate 
monobasic, trifluoroacetic acid and acetonitrile. Figure 2.4 is a schematic of how the 
digestions were carried out.  The digested peptides as shown (step B) were separated 
from the remaining cells. CHCA matrix was only incorporated afterwards (step C) As a 
result, the influence of organic solvents on the cells was not an issue.  
 
 
 
 
Figure 2.4 Schematic for on-target digestion followed by the introduction of CHCA 
matrix. (A) trypsin was added to spots for digestion (B) Digested peptides were removed 
from remaining cells (C) mixing of peptides with CHCA matrix for analyses 
 
Depending on the mass spectral analyses, the next sample handlings varied. In the case of 
MALDI MS, each spot was mixed in a 1:1 ratio with CHCA before spotting on the plate 
for analyses. As for ESI MS/MS, it will be discussed in the following section.  
 
 
mass spectrometer A 
B 
C 
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2.7   HPLC-ESI-MS/MS 
 
 
Before analyses with HPLC-ESI-MS/MS, quantification for the cleaved peptides was 
carried out. This was to ensure that the amount of our peptides were within the level of 
detection of the mass spectrometer. The minimal amount of peptides needed was 2 µg. 
For peptides, quantification can be accomplished using the BCA assay. The standard 
protein used was bovine serum albumin (BSA). The exact protocol for the BCA assay is 
presented in Appendix 3.  
For the analyses with ESI MS/MS, the slides were prepared in the droplet method. On-
target digestions using the optimal conditions of; 0.0015 mg/mL of trypsin and the 
duration of ten minutes at ambient room temperature. Of the two application methods, 
only slides prepared in the post-application were analyzed by MS.  
 
2.8   Database Searches 
 
All MALDI MS spectra were searched against the SwissProt protein database on 
MASCOT provided by Matrix Science (Peptide Mass Fingerprint, 
http://www.matrixscience.com).  The search parameters used for C. albicans were: (1) 
trypsin with one missed cleavage, (2) fungi as the taxonomy, (3) a variable modification 
for the oxidation of methionine and (4) a mass tolerance of ± 70 ppm.  
All ESI MS/MS spectra were run through the Thermo Proteome Discoverer version 
1.3.0.339 software (Thermo Fisher Scientific Inc., USA), using the algorithm known as 
SEQUEST. The C. albicans database chosen to search results against was the UniProt 
Knowledgebase, more commonly known as UniProtKB. (UniProt Consortium, 
http://www.uniprot.org/, UK, Switzerland, USA). The data analysis program known as 
SEQUEST was used for protein identification. The search parameters were as follows: 
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(1) enzymatic cleavage by trypsin with 2 missed cleavages, (2) S/N of 1.5, (3) precursor 
mass tolerance of ± 2 Da, (4) fragment mass tolerance of ± 0.8 Da, (5) modifications for 
phosphorylation on serine and threonine, and oxidation on cytosine and methionine, and 
(6) a minimum of 2 peptides per protein with high peptide confidences.  
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Section 3   Results and Discussion 
 
In Section 1, the use of MS in rapid whole cell analyses for microorganisms was 
discussed. Of all microorganisms, infections caused by C. albicans have rapidly 
progressed due to the development of resistant strains against current oral dugs. The 
peptide Hst 5 has shown to have antifungal properties in controlling C. albicans in vivo, 
but the precise mechanism of how Hst 5 is able to kill cells is not known. Current 
research has proposed that Hst 5 affects cellular respiration at the mitochondria. This may 
be so, but the influence of Hst 5 can be hypothesized to affect additional pathways. Here, 
we hypothesize that Hst 5 may exert influence on surface proteins as well. Surface 
proteins play crucial roles in allowing C. albicans to adhere to the oral cavity to initiate 
pathogenesis. The treatment of C. albicans with Hst 5 may alter the expression of these 
proteins. By performing surface digestions, we can quickly isolate surface exposed 
peptides and protein identification via MS can allow further insight towards their role in 
Hst 5.   
 
3.1   Development of On-Target Digestions of Test Protein    
        Standards 
 
In order to analyze surface proteins, a common approach is to study the peptides removed 
from the surfaces of the intact cell. To accomplish this, site-specific enzymes are used to 
cleave them off. Trypsin is commonly used for microorganism digestion, where it cleaves 
on the C-terminal end of lysine and arginine residues. A typical workflow is to subject 
cells to overnight proteolysis under conditions where cell integrity remains intact [45]. 
This allows for peptides to be released, which can be collected for mass spectral analyses. 
Although this protocol was successful, it does have the drawback of being tedious and 
time-consuming. Additionally, the longer incubation of cells with the enzyme may 
potentially cause cell lysis. Because of these reasons, the use of on-target surface 
digestions may be an improved substitution.  
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With no established protocol for an on-target approach, digestions were initially 
developed using standard proteins. First, myoglobin and then cytochrome c were 
tryptically digested overnight at 37°C, serving as a standard to which the completeness of 
the on-target digestions was compared. For the on-target digestions, the standards were 
digested for ten minutes at ambient room temperature. A total of three replicates were 
prepared for both proteins and the two digestion approaches. To begin, reference to 
myoglobin will be discussed. The comparison of digested myoglobin from both digestion 
methods are indicated in Figure 3.1. The asterisks indicated peptides belonging to 
myoglobin.  
Based solely on the number of asterisks, one can see that indeed the in-solution 
digestions yielded a few more peptides than on-target. In addition, the relative peak 
intensities were lower from on-target digestions. Although the appearances of the spectra 
seemed identical, this was not the only indication of whether they were equivalent. To 
supplement the spectra, MASCOT database searches were also completed. The results 
were able to identify the protein, as well as determine the amount of sequence coverage. 
The sequence coverage refers to the number of observed amino acid residues relative to 
the total number in the protein. The database results for both digestions were successful 
in identifying myoglobin as the protein. The average sequence coverage with standard 
deviation (s.d.) of myoglobin was determined to be 77 s.d. 3% for in-solution, and 62 s.d. 
5% for on-target. Likewise, the average coverage for cytochrome c was 83 s.d. 8% and 
67 s.d. 3%, respectively. Despite the loss in the number of peptides and sequence 
coverages, it can be concluded that the on-target method developed was sufficient. 
Lastly, the on-target approach offers advantages such as; greatly reducing digestion times 
from overnight to ten minutes, and minimizing the volumes of materials.  
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Figure 3.1 MALDI MS spectra of the in-solution and on-target tryptic digests of 
myoglobin. Three replicates were performed in total. The in-solution digestion was the 
standard protocol used for digesting proteins. In the on-target approach, the digestion was 
carried out for 10 minutes at room temperature. Asterisks (*) represent peptides of 
myoglobin. The average sequence coverage with standard deviation for in-solution was 
77 s.d. 3% and on-target was 62 s.d. 5%.  
 
To help improve the completeness of the digestions, the investigation of digestion times 
were explored. Both standard proteins were analyzed; however, here we will discuss 
cytochrome c. The times ranging from seconds to one hour were tested. These included 
times at 15, 30 and 45 seconds; and 1, 2, 3, 4, 5, 10, 15, 20, 25, 30 and 60 minutes. Three 
replicates of cytochrome c digestions were prepared for each time mentioned. It was 
determined that the shorter digestion times, from 15 seconds to 4 minutes, were not long 
enough to allow trypsin to digest the standards. Likewise, increasing the digestions from 
20 minutes until 1 hour provided no additional peaks relevant to cytochrome c. As such, 
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it was determined that the critical times ranged from 5 to 15 minutes. To start the 
comparisons, focus will be placed on three of the easily observed peptides with no missed 
cleavages, m/z of 1168.62, 1598.56 and 1633.41, from cytochrome c. At five minutes, the 
ion counts with standard deviations (s.d.) were; 30000 s.d. 75000, 2600 s.d. 150 and 
17000 s.d. 2900 respectively. Between five and ten minutes, it was determined that at ten 
minutes, the presence and intensity of peaks had increased. At ten minutes, the counts 
were; 440000 s.d. 25000, 4800 s.d. 580, and 6500 s.d. 4700 respectively. This large of an 
increase meant that trypsin was given enough time to effectively cleave off peptide 
molecules. Therefore, this indicated that ten minutes allowed for a more completed 
digestion. Five minutes was still not long enough for trypsin to reach and cleave the 
peptides. At fifteen, a large drop in the ion counts was observed. The counts were; 
380000 s.d. 26000, 430 s.d. 120, and 3800 s.d. 770 respectively. A possible explanation 
for this would be the adsorption of peptides to the solid surface. The longer time would 
allow for more adsorption, and consequently, less would be recovered for MS detection. 
As a result, a loss in the ion counts would be expected. Due to this reason, it was 
concluded that ten minutes was optimal for the digestion of cytochrome c. However, the 
optimal digestion time is specific to each substrate, and thus it needs to be re-examined as 
will be the case for proteins of C. albicans.  
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Figure 3.2 MALDI MS spectra for the comparison of digestion time for the on-target 
digestions of cytochrome c. Three replications of each time were analyzed. The digestion 
times were varied from 5-15 minutes. Peaks belong to cytochrome c are marked with 
asterisks. The three m/z peaks belong to peptides of cytochrome c discussed are labelled 
with; 1168.62, 1598.56 and 1633.41. 
 
3.2   C. albicans Adhesion on Glass Slides 
 
The analyses of surface proteins for C. albicans were commonly done while in-solution. 
In this workflow, cells were grown on SDA media, resuspended in a buffer and 
enzymatically digested overnight. This may work as it will allow for the identification of 
surface proteins; however, it does not truly represent the adhesion process. The adhesion 
process becomes crucial as a requirement for C. albicans to penetrate the oral cavity.  In 
order for the expression of these specific proteins, the process of adhesion must have 
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occurred or is occurring. Unfortunately, the factors driving the adhesion process remains 
unknown. Factors such as the type of microorganism, material surface characteristics and 
the presence of other proteins, can influence attachments. 
To start, the ability of C. albicans to attach to a solid support was tested. For this, a bare 
glass slide was immersed into a solution of cells, with the resulting image shown in 
Figure 3.3A. As can be seen, no cells have attached to the slide, which indicated another 
component was needed for adhesion. Chaffin demonstrated when beads were coated with 
any of the extracellular matrix (ECM) proteins, the yeast and pseudohyphae forms bound 
[46]. ECM proteins include albumin, fibronectin, fibrinogen, laminin and denatured 
collagen. The way in which these proteins aid in adhesion remained unclear. They have 
been hypothesized to help in three ways; first, to bind the substrata surfaces to allow for 
colonization, second, to bind the surface of the microorganism and then colonize, and 
lastly, to be present in the solution during the adhesion process [47].  
Previous work completed by the Siqueira Lab has shown that C. albicans can bind to one 
of the ECM proteins known as human serum albumin (HSA) [30]. HSA has been 
identified as a relevant component in the oral cavity. It was reported to serve as a receptor 
for initial adhesions [46]. By applying HSA to the glass slide first, thereby creating a pre-
coated surface, C. albicans has the potential to attach. An image of a slide containing the 
pre-existing layer of HSA was shown in Figure 3. It can be clearly seen that HSA was 
necessary for cells to bind. The larger spots observed were cells that have begun to 
adhere to one another, forming groups called colloids by a process known as flocculation 
[2]. Despite washings of the slides, colloids remained, as highlighted by the red circle. 
This was negligible, as the amount of cells was minimal. 
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Figure 3.3 Microscope images of C. albicans adhered glass slides. (A) No C. albicans 
adhesion on glass without HSA coating. (B) C. albicans adhered to HSA.  
 
 
3.3.   Influence of Hst 5 on Adhered Cells  
 
With successful adhesion of C. albicans, Hst 5 was introduced into the system next. As 
discussed in Section 2, Hst 5 was applied in two different methods; pre-application which 
meant Hst 5 was applied before cell introduction and, post-application where Hst 5 was 
introduced after cells. The 0.030 mg/mL concentration of Hst 5 will be used to discuss 
the differences in both methods. By applying Hst 5 prior to C. albicans adhesion, cell 
removal was observed. An image from the pre-application method is shown in Figure 
3.4B. A control, where no Hst 5 was used, served as the basis to which the concentrations 
were compared. The average values with standard deviations (s.d.) were listed in Table 
3.1. The control had an average cell count of  110 s.d. 41, whereas pre-application was 13 
s.d. 2. The reduction in cells may be attributed to the pre-existing layer of Hst 5. This 
layer of Hst 5 seemed to act as a preventive layer, allowing fewer cells to attach. Equally 
in its ability to cause cell removal was the post-application approach. Figure 3.4E was an 
image of the resulting slide. The average cell counts for post-application was 16 s.d. 8, 
which was roughly the same as pre-application. These results indicated that the influence 
of Hst 5 on C. albicans was independent on when Hst 5 was introduced to the cells.  
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Next, the effects of varying concentrations Hst 5 were also investigated. The 
physiological concentration of Hst 5 found in the human body was reported to be 10-30 
µM [48]. Thus far, only a concentration of 10 µM (0.030 mg/mL) has been applied 
towards treating C. albicans.  Lower Hst 5 concentrations became of interest in hopes of  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4 Microscope images of C. albicans adhered to slides. Four replicates were 
imaged and cells were counted. Both pre-application and post-application methods were 
investigated (A) Control, (B-D) Pre-application; 0.030, 0.025 and 0.020 mg/mL 
respectively (E-G) Post-application; 0.030, 0.025 and 0.020 mg/mL respectively. The 
corresponding average counts for each condition is shown in Table 3.1 
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Table 3.1 The average number with standard deviations (s.d.) of cells remaining when 
exposed to Hst 5 from four replicates. Pre-application, Hst 5 before cells attachments, and 
post-application, Hst 5 after cell attachments, were analyzed.  The control had an average 
of 110 s.d. 41 cells.  
 0.030 mg/mL Hst 5  0.025 mg/mL Hst 5 0.020 mg/mL Hst 5 
Pre-Application  (A) 13 s.d. 2 (B) 18 s.d. 4 (C) 47 s.d. 7 
Post-Application (D) 16 s.d. 8 (E) 25 s.d. 5 (F) 42 s.d. 4 
 
determining the lowest threshold that may be reached before no changes in adhesion were 
observed. Two lower concentrations, 6.6 µM (0.020 mg/mL) and 8.2 µM (0.025 mg/mL) 
were tested. Four repeats of each concentration was analyzed. Microscope images taken 
for both concentrations in both application methods are shown in Figure 3.4C-D and F-G. 
Again, our results showed that no difference between pre- and post-application of Hst 5.  
For the determination of the lowest threshold of Hst 5, Table 3.1 indicated that 0.025 
mg/mL was the lowest we could go. When compared to the control, it was determined 
that all three of the Hst 5 concentrations demonstrated the ability to reduce the number of 
adhered cells. Between 0.030 and 0.025 mg/mL, the two concentrations appeared to have 
the same cell removing ability, as the average number of cells was similar. However, 
upon using 0.020 mg/mL, the number of cells remaining increased greatly. The cell 
counts results revealed that 0.020 mg/mL was significantly weaker.  
 
3.4   On-Target Digestions of C. albicans 
 
Ideally, on-target digestion will allow for the removal and sampling of peptides on the 
surface of C. albicans without lysing the cells. The internal components from lysed cells 
complicate mass spectral data, essentially by acting as non-informative background ions. 
In the work done by Rodriguez-Ortega et al., cells of C. albicans were simply incubated 
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with trypsin, thereby separating them from remaining cells [14]. Their work yielded only 
proteins with origins at the cell surface. Because our developed digestion protocol varied 
from theirs, the absence of cell lysis needed to be verified. By centrifuging cells at a 
speed of 13000 rpm, the cell lysate was prepared. As a preliminary experiment, the mass 
spectrum of the cell lysate was obtained. The results indicated that the spectrum for on-
target digestions produced substantially fewer peaks (spectrum not shown). Therefore, it 
appeared that the on-target digestion was able to at least reduce the extent of cell lysis, if 
not entirely preventing it.   
The next task was to optimize the trypsin quantity for the on-target digestion of proteins 
on adhered C. albicans. A total of five concentrations of trypsin were tested; 0.0005, 
0.00075, 0.0010, 0.0015 and 0.0020 mg/mL. For each concentration explored, five 
replicates were done. Of the five concentrations, the optimal concentration of trypsin was 
determined to be 0.0015 mg/mL. Based on the intensity of a resulting peptide 
characteristic to C. albicans, at m/z of 1758, insignificant intensities were obtained at the 
two lowest concentrations studied. At 0.0010 mg/mL, the ion count and standard 
deviation for this peak was 4000 s.d. 300. Then at 0.0015 mg/mL, it was 7000 s.d. 2000. 
Finally, at 0.0020 mg/mL, the ion count decreased to 4000 s.d. 300. This indicated that 
0.0015 mg/mL provided a more complete digestion than 0.0010 mg/mL.  
 
3.4.1   Determining the Optimal On-Target Digestion Time for C. albicans 
As already discussed in Section 3.1, the optimal digestion time determined from the test 
standard proteins was ten minutes. Because the sample used here was different, the time 
required for digestion was re-evaluated. Previous work done by Hernaez et al.  performed 
the isolation of surface peptides from C. albicans with variations in digestion times [49]. 
They investigated different times ranging from five to twenty minutes in five minute 
intervals, whereby they concluded that five minutes was sufficient for the release of 
easily accessible surface peptides. They also determined that as the time was increased, 
the number of resulting peptides increased as well. Paralleling their work, times of five, 
ten, fifteen and twenty minutes were tested and the resulting spectra were shown in 
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Figure 3.5. Because the peaks pertaining to C. albicans were not known at that time, 
specific comparisons of five replicates were made based on the peak with a m/z ratio 
around 1500. This peak was neither an autolytic trypsin peak nor one from HSA; 
therefore it was hypothesized to be one from C. albicans. 
At five minutes, few peaks were observed in the mid to upper mass range. This was likely 
due to the fact that trypsin was not given enough time to diffuse to the cells for the 
removal of surface proteins. At ten minutes, a more completed digestion was observed. 
This statement was made based on the appearance of the spectrum, and was supported by 
the ion counts of the m/z peak around 1500. At five minutes, this peak was not present. 
But at ten minutes, the count and standard deviation was 5100 s.d. 1300. Not only did the 
count increase, but the appearance of more peaks signified a more completed digestion; 
therefore, concluding five minutes was too short. Likewise, at fifteen minutes, the same 
peaks seen at ten minutes were observed, however the intensities have decreased. This 
was indicated by the reference peak which had an ion count of 3400 s.d. 1100. At twenty 
minutes, it was expected the intensities of the peaks should have increased. However, 
what happened was in fact the opposite. Here, not only did the peak at 1500 appear lower 
in Figure 3.5, but the ion counts decreased to 3100 s.d. 1100, which was similar to fifteen 
minutes. Together, the ion count and appearance of the spectra indicated that twenty 
minutes was not better than fifteen. Interestingly, this produced parallel results to the 
standard proteins in Section 3.1, where no additional information was gained as the 
digestion times increased. Again, the same reasoning from before can be applied here. 
The nonspecific adsorption of peptides to the slide decreases the number of ions available 
for MS analyses.  
Hernaez et al. have also reported that the longer the digestion, the greater the number of 
peaks observed [49]. Our results here have shown otherwise. The numbers of peaks have 
not increased by a significant amount when comparing ten, fifteen and twenty minutes. 
Instead, only the ion counts have changed. It should be stressed that their digestions were 
performed in-solution with 37ºC incubations. Digestions carried out while in-solution 
offers a significant advantage as the number of cells is much larger. In contrast, our 
digestions here become strongly influenced by the total number of cells attached to each 
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slide, which easily differ between replicates. Based on these results, it was determined 
that ten minutes provided the better digestion time.  
 
  
Figure 3.5 MALDI MS spectra for the comparison in surface digestion times of adhered 
C. albicans treated with Hst 5. Five replicates were analyzed. Average ion counts and 
standard deviations (s.d.) for the peak around 1500 were listed.  
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3.5   Analysis of Peptides from C. albicans by MALDI MS  
        Following Treatments with Hst 5 
 
With the capability of performing on-target surface digestions on C. albicans, we were 
able to determine changes in the resulting peptides due to treatments with Hst 5, and 
hopefully the results may provide insight towards which proteins and pathways are 
involved in the mechanism of Hst 5. Both application methods of Hst 5 were analyzed 
where four replicates were performed for each. From each replicate, the removal of 
background signals such as keratin, matrix peaks, trypsin autolytic peaks, and peptides of 
HSA was done. The data was searched against the C. albicans genome database, with 
tentative protein identification. This led to a list of twenty m/z peaks assumed to be 
characteristic only to C. albicans. All peaks have been assigned except for the m/z peak at 
2294.92 in Table 3.2. This was because the C. albicans database remains incomplete.  
The number of m/z peaks obtained was significantly lower than those when done in-
solution. In 2010, Hernaez et al. carried out a similar workflow to identify surface 
proteins, and they were capable of identifying fifty proteins [49]. In their work, C. 
albicans was treated with Hst 5, digested by trypsin and separated by HPLC. Mass 
spectral analyses were performed using a MALDI TOF-TOF mass spectrometer. Because 
their digestions were performed while in-solution, they were not limited the number of 
cells. In our studies, the number of cells exposed to trypsin was limited. Only those that 
have successfully adhered to HSA would have undergone digestion. As a result, it was 
expected that fewer proteins would be identified. Nonetheless, with our rapid and more 
targeted approach, a large number of peaks were observed.  
The presence of antibiotics decreases microorganism adhesion depending on the 
susceptibility of the species and the concentration of antibiotic used [47]. This can 
regulate adhesion at both the cellular and molecular level. As a result, these changes were 
elicited via which proteins were expressed. Hst 5, although not an antibiotic, may be 
classified as an antimicrobial agent capable of causing changes in protein expressions. In 
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MS, changes in protein expression can be linked semi-quantitatively via the ion counts of 
the detected peptides. In this experiment, we are interested in  peaks that either 
significantly decreased or increased after treatment with Hst 5.Hence, m/z peaks with no 
changes were disregarded. 
To begin, peaks with large decreases in their ion counts are discussed.  Table 3.2 contains 
the identified m/z peaks and their corresponding counts. The tentative protein 
identification, amino acid sequences and their biological functions are listed as well. With 
regards to the Hst application method, the results here demonstrated that both pre- and 
post-treatments had a decreasing trend. It can be suggested that these proteins are the 
cell’s defense mechanism against antifungal agents. For these proteins, it became difficult 
to conclude that a decrease in ion count was truly representative of down regulation. This 
was because the decrease may have also occurred as a result of the loss in cells. A loss in 
cells would mean less peptides are available for analyses, therefore already constituting a 
decrease in ion counts. Therefore, the use of ESI-MS/MS may provide validation of these 
decreasing changes.  
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Table 3.2. Database identified proteins from four replicates of on-target digestions of C. albicans treated with Hst 5. Both pre- and 
post-application of Hst 5 have been included. Decreasing average ion counts and standard deviations (s.d.) have been listed. The 
period (.) represents the site of enzyme cleavage and the dash (-) represents the end of the terminus. 
m/z 
Before 
Treatment 
 
(Avg. Counts 
and s.d.) 
Pre-
Application 
 
(Avg. Counts 
and s.d.) 
Post-
Application 
 
(Avg. Counts 
and s.d.) 
Amino Acid Sequence Protein Functions 
802.00 
1433.70 
1677.80 
1758.60 
150 s.d. 30 
1400 s.d. 90 
350 s.d. 70 
770 s.d. 20 
30 s.d. 10 
0 
220 s.d. 40 
180 s.d. 180 
0 
700 s.d. 100 
0 
150 s.d. 60 
IAQQDNGK.G 
R.YGAGAGHPHRALAR.R 
-.MSWFGFFDPDFDDFFGRPR.K 
K.GQQVSRYGAGAGHPHR.A 
Small heat shock protein 21 
 
Virulence and stress response 
797.33 440 s.d. 120 0 230 s.d. 160 
K.YDDEKK.Q 
 
 
R.ALFSGFR.F 
Cell wall protein RHD3 
 
Presequence translocated-
associated motor subunit 
PAM17 
Pathogenesis and cell wall 
organization  
 
Transport of peptides from inner 
membrane to mitochondrial 
matrix 
2184.74 6400 s.d. 30 1700 s.d. 2300 1940 s.d. 260 K.TGHSGTLDPKVTGCLIVCIDR.A 
Centromere/microtubule 
binding protein CBF5 
Chromosome migration 
2214.50 3600 s.d. 400 600 s.d. 80 630 s.d. 50 
K.CVVVGDGAVGKTCLLISY 
TTSK.F 
Cell division control 
Protein 42 homolog 
hyphal formation, virulence, 
morphogenesis 
2214.50 3600 s.d. 400 600 s.d. 80 630 s.d. 50 K.LALVGISFVPLVLLVTVLYGK.I 
Alpha-factor-transporting 
ATPase 
ATPase activity and binding 
2294.92 7700 s.d. 3200 610 s.d. 910 580 s.d. 260    
2304.80 1600 s.d. 900 340 s.d. 4 280 s.d. 50 
K.ENLDWFKPFDLARFPVDPK.D 
 
 
R.VTDEILQLVPKPTVFKHALR.C 
Acetyl-coenzyme A 
synthetase 1 
Poly(A) polymerase 
PAPa 
ATP binding 
 
 
mRNA polyadenylation and 
biofilm formation 
 
2310.00 1300 s.d. 200 0 420 s.d. 60 
K.ETDESYHELINKWENEMK.- + 
Oxidation (M) 
Uncharacterized protein 
YAE1 
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2322.82 1200 s.d. 120 200 s.d 30 640 s.d. 140 
 
Adherence factor 
surface antigen mediating 
adhesion and aggregation 
2326.96 1200 s.d. 110 0 430 s.d. 40 
K.FVSISVPILYGNHAIKLTPEK.R 
 
 
 
R.VDVLLIIVHAITFSVSDKATGK.Y 
 
 
R.AYMMDPWWSPSIEDQAIDR.I  + 
Oxidation (M) 
Protein AF-9 homolog 
 
 
Probable ferric reductase 
transmembrane component 
 
DNA repair protein 
RAD5 
DNA repair, transcription and 
histone acetylation 
 
 
 
Ion transport 
 
 
DNA, ATP and Zn binding 
2334.50 1400 s.d. 600 300 s.d. 500 630 s.d. 50 
K.LTSQEFWEHIFNIFEINK.F 
K.DTFAAAALACGEKYYQVASSIR.
T 
 
K.ENLDWFKPFDLARFPVDPK.D 
 
 
K.VQALILVPTRELALQTSQVVR.T 
Alpha-1,2-
mannosyltransferase 
 
 
Acetyl-coenzyme A 
synthetase 1 
 
ATP-dependent RNA 
helicase DHH1 
protein mannosylation 
 
 
 
acetyl-coA biosynthesis 
 
 
ATP and RNA binding (body 
assembly) 
2571.95 820 s.d. 90 0 310 s.d. 160 
K.DEEDDESSDDDDSDDDDTALLL
K.E 
Pre-mRNA-splicing factor 
WC15 
Pre-mRNA splicing 
3175.19 1300 s.d. 130 0 100 s.d. 10 
MSEVNETCKPQACAIQNCLEKNG
YNESR.C + Oxidation (M) 
Cx9C motif-containing 
protein 4 
Involved in the transfer of 
disulfide bonds to proteins 
entering mitochondria 
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In the second part, we sought peaks with large increases in ion counts following Hst 5 
treatment. Higher emphasis may be placed on these peaks because despite the loss of 
cells due to Hst 5, an increase in ion counts was observed. From the peaks identified, the 
only increases in counts were for proteins who made new appearances after treatment. 
There was no increase for peaks already present prior to treatment. Table 3.3 contains the 
four peaks and their changes in ion counts. In addition, their tentative protein 
assignments, amino acid sequences and their biological functions were listed.  Both 
application methods were used and the ion counts from both are listed. The five peaks 
verified the results seen in Table 3.2, in that both the pre- and post-application method 
revealed the same increasing pattern. Based on this trend, it can be hypothesized that the 
tentative proteins are undergoing an up-regulation in expression. It can be proposed that 
these proteins aid Hst 5 in accessing C. albicans whereby it can elicit its antifungal 
effects. Higher emphasis may be placed on these peaks because despite the loss of cells 
due to Hst 5, a noticeable increase in counts was observed. Therefore, confirmation of 
their identities will provide interesting insight on how Hst 5 works. 
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Table 3.3. Database identified proteins from four replicates of on-target digestions of C. albicans treated with Hst 5. Both pre- and 
post-application of Hst 5 have been included. Increasing average ion counts and standard deviations (s.d.) have been listed. The period 
(.) represents the site of enzyme cleavage and the dash (-) represents the end of the terminus. 
 
 
m/z 
Before 
Treatment 
 
(Avg. Counts 
and s.d.) 
Pre- 
Application 
 
(Avg. Counts 
and s.d.) 
Post-
Application 
 
(Avg. Counts 
and s.d.) 
Amino Acid Sequence Protein Functions 
641.24 
953.50 
0 
0 
280 s.d. 80 
560 s.d. 70 
300 s.d. 10 
420 s.d. 80 
K.MESMK.Q + Oxidation (M) 
Increased 
recombination centers 
protein 6 
Chromosomal rearrangement and 
telomere healing 
669.24 0 710 s.d. 750 610 s.d. 190 K.YDDEK.K 
Cell wall protein 
RHD3 
Pathogenesis and cell wall 
organization 
695.35 
841.44 
0 
0 
1000 s.d. 100 
170 s.d. 70 
980 s.d. 110 
43000 s.d 110 
-.MAKTTK.V + Oxidation (M) 
ATP-dependent RNA 
helicase HAS1 
40S ribosomal subunit biogenesis 
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The proteins identified in both tables have cellular origins relating back to the cell 
surface. These proteins were cell wall protein RHD3, small heat shock protein 21, cell 
division control protein homolog 42, adherence factor and alpha-1,2-
mannosyltransferase. This supported the assumption that the protocol developed for 
digestion proteins on cell surfaces was successful. The experimental conditions chosen 
were adequate to cleave surface proteins, yet mild enough to disfavour cell lysis. For 
some of the identified proteins, origins pertaining to the nucleus were observed. Initially, 
this contradicted the theory of digestion without cell lysis; that is, the only way nucleus-
associated proteins can be identified was if the cells were lysed. It has been recently 
discovered that certain proteins belong to a group known as moonlighting proteins. 
Moonlighting proteins are multifunctional proteins that originate from one cellular 
compartment, and then are transported to another whereby they perform different 
functions. The protein, alpha-1,2-mannosyltransferase, has a potential of being a 
moonlighting protein. Two locations, the Golgi apparatus and cell membrane, were 
determined for this protein. However, its listed functions have roles associated at the cell 
surface. Because of this, there may be a possibility for the presence of other moonlighting 
proteins. 
Another protein of particular interest was the small heat shock protein 21 (Hsp21). Not 
only did it have an origin and functions at the cell surface, but its identification seemed 
more reliable. In Table 3.2, four different masses and peptide sequences have been shown 
to identify this protein. This not only meant that Hsp21 could be identified more 
accurately, but there was a high possibility for its presence. Hsp21 was determined to 
have functions as a coping mechanism for C. albicans in coping with thermal and 
oxidative stresses [50]. Hst 5 may have functioned as a stressor, therefore, C. albicans 
would have responded by changing the expression of Hsp21 in hopes of allowing cell 
survival. With the mention of oxidative stresses, the expression of  Hsp21 strongly 
suggested the theory that Hst 5 affects cellular respiration may be correct.  
 
 
 42 
 
3.5.1   Limitations of MALDI MS Analyses 
Thus far, we have demonstrated the ability of MALDI-MS to analyze large changes in 
the protein expression after Hst 5 treatment. This was observed through large changes in 
ion  counts. The identities of these proteins and their roles in biological pathways, allows 
focus on the key biological processes Hst 5 may influence. Unfortunately the proteins 
identified in Tables 3.2 and Tables 3.3, were only tentative. To confirm their identities, 
further identification would be required. Tandem MS (MS/MS) would allow for the 
determination of their amino acid sequences. These sequences would be more specific, 
allowing for a more specific identification.  
MALDI MS/MS has been performed on the m/z peaks observed; however, the results 
were inconclusive. One problem was the intensities of the observed peaks. To obtain a 
sufficient MS/MS spectrum, the precursor peak must have an ion count of at least 2000. 
When it is less, fragmentation becomes difficult and the spectrum can become noisy. This 
was observed for the majority of the peaks. Their counts were not high enough to 
undergo a second fragmentation. Figure A.1 was the spectrum obtained for the m/z peak 
of 1677.86. Here, the second fragmentation was possible but as one can see, the spectrum 
greatly suffered from background signals. The sequencing of the amino acids was 
attempted, but due to the noise, it was difficult to distinguish between a signal from the 
background and one from the amino acid. Automatic sequencing such as de novo 
sequencing, can be used instead, however, this did not work for the acquired spectra. 
To overcome this, additional sample cleanup was necessary. This will help remove any 
signals from salts and buffers, allowing improved fragmentation. With that in mind, ESI 
became a more suitable option as it can be easily coupled with LC. LC will allow for the 
cleanup via further separation of the components. And with its ability to operate in a 
continuous online mode, MS/MS can easily be acquired for all precursor ions as the 
fractions leave the column. One focal point with ESI was its ability to automatically run 
MS/MS spectra through databases such as SEQUEST, allowing for all probable amino 
acid sequences within a selected species.  
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Between the different Hst 5 application methods, both pre- and post-application offered 
similar results. Both identified approximately the same number of m/z peaks, and the 
changes in ion counts demonstrated the same trends. For further research however, with 
interest towards clinical applications, it was decided that focus would be placed on post-
application. For example, take the situation where an individual has already contracted 
the pathogen. This can represent the situation of C. albicans adhered to HSA in the oral 
cavity. For them, administering Hst 5 would occur next, which is parallel to our post-
application method. In this aspect, we would be addressing the role of Hst 5 as a 
treatment, rather than used as a prevention. In the next section, ESI MS/MS will be used 
on post-application prepared slides. The appearance of the same list of m/z peaks from 
MALDI MS will be searched in hopes of further confirming their identifications via 
tandem MS.   
 
3.6   Analysis of Peptides from C. albicans by HPLC-ESI-MS/MS   
         Following Treatment with Hst 5 
 
3.6.1   Quantification of Total Peptide Concentration Prior to Sample  
              Injection 
Prior to injecting the sample into the instrument, quantification of the peptides was 
carried out. The linear trap quadrupole (LTQ) linear ion mass spectrometer used had a 
lower level of detection at 0.002 mg. Since, peptides have molecular weights less than 
4000 Da, a BCA assay was used. In the BCA assay, quantitation of proteins with low 
molecular weight and peptides were done via reactions with Cu
2+
 ions. The specific 
reactions involved in the BCA assay are discussed in Appendix 3. In addition, the 
protocol for standard preparation and measurements are explained. Absorbance values of 
the standard protein, bovine serum albumin (BSA), was used to extrapolate the quantity 
of peptide. This assay was performed on the digested peptides from a single droplet spot 
with a volume of 1.50 µL. The standard curve had an equation of y = 0.000x-0.021, R
2
 = 
0.9662. It was therefore determined that from a digestion volume of 1.50 µL, the mass of 
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peptides was 0.5050 mg/mL. Therefore, for a single spot with a volume of 1.50 µL, the 
mass of the peptides was 0.7575 mg. To meet the lower level of detection, three spots 
were combined as one replicate. From MALDI MS results, one significant limitation was 
quantitative comparisons between data sets due to different cell counts. Therefore the 
BCA assay, may somewhat act as a normalization in minimization large variations. 
 
3.6.2   Database Search Results for Protein Identification  
 
Prior to injection into the instrument, peptide solutions were dried and resuspended in 
0.1% formic acid. Together, both HPLC and ESI MS/MS data were produced. However, 
what was of more importance was the MS/MS data acquired. MS/MS spectra allowed for 
the direct input into SEQUEST, an algorithm that searches against selected databases. All 
spectra were run against the C. albicans database acquired from UniProt. In this way, all 
mass spectral peaks were used, tentatively identifying all possible proteins correlating to 
the observed masses. To be considered a protein of interest, it must have been identified 
in both the untreated and treated samples with the same ascension number. In this way, 
we can relate a change in protein expression as significant.   
A total of six replicates were prepared and analyzed by HPLC-ESI-MS/MS. All resulting 
spectra were searched against the C. albicans database, with the tentative protein 
identifications shown in Table 3.4. Again, without completion of the database, m/z 
assignments would not be possible. As an alternative, the concept of identifying peaks via 
protein families was used. Those identified in this manner were represented with an 
asterisk. Protein families include proteins who share similarities in sequences, structures 
and functions. Unfortunately, even when assignments were done via protein families, 
several proteins were still not identified. New protein entries are entered daily into these 
databases, therefore when needed; the spectra can be searched again more frequently in 
hopes of identification.  
Upon comparison between MALDI and ESI MS results, the list of masses identified was 
different. This can be due to different sample bias during both ionizations. Another 
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probable explanation may be due to the sample cleanup during the ZipTip protocol. 
When the ZipTip was used, the loss of peptides during numerous binding and washing 
steps was expected. In the case of the digested peptides, the washings may have 
potentially removed the peaks observed previously from MALDI MS results. This would 
then produce a set of new masses following analyses. Another reason may be because 
sample cleanup may have removed abundant contaminants. The presence of these 
contaminants would mask the peptides of interest, which were already of lower 
concentrations. As a result, this would allow for new peaks to be observed in ESI MS/MS 
only. And lastly, there may be a possibility that the peaks identified in MALDI MS may 
have been by chance. The performance of MS/MS would have allowed for us to 
determine their amino acid sequences, and subsequently whether or not they were truly 
peptides.  However as already discussed, MS/MS was not possible with MALDI MS.  
Similar to the MALDI MS results, Table 3.4 was examined for changes in ion counts. For 
a change in ion count to be concluded, the standard deviations were taken into 
consideration. When changes fell outside the standard deviation, a change was concluded. 
Again, the two trends of decreasing and increasing counts were observed. Ion counts that 
have decreased following Hst 5 exposure were bolded in blue, and those with increases 
were bolded in red. Similar to the results from MALDI MS analyses, those with 
increasing counts were of more interest. This was because even with the reduction of 
cells adhered, an increase in expression for these proteins was seen. For those that did not 
show changes outside the standard deviation, a change could not be concluded. As a 
result, Table 3.4 categorizes the results according to which biological pathway they were 
associated with. 
Due to the difficulties in basing our results solely on ion changes, more emphasis will be 
placed towards the biological pathways affected. Being able to identify specific 
biological pathways may allow for better focus on how Hst 5 works. In addition, it will 
allow research to become more targeted towards proteins in these key processes. Our 
results in Table 3.4 have been classified into eight categories; (A) virulence, (B) surface-
associated, (C) mitochondrial-associated, (D) DNA binding, (E) protein synthesis, (F) 
signalling, (G) miscellaneous and (H) uncharacterized. For those in the miscellaneous 
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group, no common pathway was found amongst the proteins. Those within the 
uncharacterized group have no identification due to the incomplete C. albicans database. 
However, frequent searches may be done as the new entries are added in hopes of 
identification. The first four pathways will be our focus for the remaining of the 
discussion. 
Before discussing each specific pathway, the conflicting changes in each group will be 
addressed. Conflicting changes are situations where one or more m/z peak exhibited an 
opposite trend compared to the majority within same group. Table 3.4 contains number in 
parenthesis beside each amino acid sequence. These values, known as XCorr, correspond 
to the scoring system of the database searches. XCorr will score the number of fragment 
ions common to two different peptides of the same precursor mass [51]. The cross-
correlation score is then presented from all peptide candidates provided from the 
database. To be considered a "good" match, the XCorr value must be two or greater. In 
the surface-associated proteins (Group B), only the mass of 1297.59 indicated an 
opposing trend. As listed, the XCorr value was 1.82. This lower value suggested that the 
identification of the protein, and consequently, its ion change, was not reliable. The same 
can also be said for the proteins with masses 575.44 and 1297.59 of the DNA binding 
proteins (Group D).  
With previous work indicating the antifungal ability of Hst 5 in controlling C. albicans 
[35] , proteins involved in virulence were assessed. The ion counts of these proteins were 
expected to decrease following Hst 5 exposure, which was observed for all listed in (A). 
The decrease for these proteins indicated that the ability of Hst 5 to affect the 
pathogenesis of C. albicans. For example, the protein of the β-lactamase family (m/z of 
4115.51) had a function with regards to resistance of C. albicans. This protein may 
potentially aid C. albicans in withstanding the host's immune system. Therefore, a 
decrease in its expression would lower the defense of C. albicans, making it susceptible 
to the immune system in the host. Similarly, the protein kexin was identified to be 
involved in the production of toxins. A decrease in expression could correlate to a 
decrease in the amount of toxin produced, therefore weakening the pathogenesis of C. 
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albicans. Overall, these results demonstrated the ability of Hst 5 to decrease the virulence 
of C. albicans. 
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Table 3.4. Database identified proteins from on-surface digestions by HPLC-ESI-MS/MS. Six replicates were analyzed from C. 
albicans treated with Hst 5 in the post-application method. Average ion counts are listed with standard deviations (s.d.). Proteins 
indicated with an asterisk (*) have between determined using their protein families. Blue represented those with decreasing ion counts, 
and red for increasing ones. XCorr score values are listed in parenthesis.  
 
Biological Pathways Mass 
Ion Counts 
Amino Acid Sequence Protein Name Functions 
Before After 
A)    Virulence 
 
 
 1284.83 
27000 
s.d. 
9500 
14000 
s.d. 
2800 
K.sLYTISPNKGK.R   (2.52) 
 
 
 
K.SKYNLPFAMK.E   (3.75) 
 
Transcriptional 
regulator STP3 
 
 
Candidapepsin-7 
 
Filamentous growth 
 
 
Supplies nutrients and 
degrades proteins 
involved in host's 
immune system 
1295.87 66000 
s.d. 
1100 
19000 
s.d. 
 7000 
R.tKKWGLGWIK.N   (1.61) Integrase family* 
DNA recognition 
between phage and 
bacterial attachment sites 
3579.79 
40000 
s.d. 
5000 
31000 
s.d. 
36000 
HPQYsEACsAVmVVTYSSGSGEHIH 
TTDIK   (3.33) 
Kexin 
 
Enzyme that produces 
killer toxins 
3895.36 
 
 
4659.96 
36000  
s.d. 
4100 
 
15000 
s.d. 
1100 
26000 
s.d. 
31000 
 
3200 
s.d. 
 2700 
ELKTTVIVTSCFNNVCSETsITT 
PKtAVtATtSK   (3.1) 
 
K.HLTLKSSTPASTLEYSTSIPPALATTSSS
LStESTtLttISR.S   (3.25) 
Flocculin* 
Needed for invasion and 
pseudohyphae formation 
in nitrogen starved 
environment 
4115.51 
51000 
s.d. 
12000 
24000 
s.d. 
17000 
 
VTFVEKAtSTSTTNtTttTTTTTTTTTTTTTI
PVKR   (3.23) 
 
β-lactamase 
family* 
 
Resistance 
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4121.03 
31000 
s.d. 
23000 
17000 
s.d. 
 7200 
K.NVKVITTTTTtSPSSFSSSSSLMsPITPQT
PNIPKTPK.T   (3.94) 
PX domain* 
 
 
Phosphatidylinositol 
binding 
 
B)   Surface-associated 
1175.88 
64000 
 s.d. 
3900 
22000  
s.d. 
 1100 
R.tINLDsQVK.Y   (3.16) 
3'(2'),5'-
bisphosphate 
nucleotidase 2 
 
Phosphatidylinositol 
phosphorylation 
1297.59 
18000  
s.d. 
8800 
51000 
s.d. 
 5400 
K.KPsTEDtFSK.Y   (1.82) 
Peroxisomal protein 
family* 
Membrane component, 
lipid metabolism and 
decomposition of H2O2 
1295.87 
66000  
s.d. 
1100 
20000 
s.d. 
7000 
mQTSISttTIEDHLHHYsPEESQKLLSRESSI
NTDLFK.E   (3.13) 
Bud site selection 
protein BUD4 
Establishes the axial 
budding pattern, induces 
hyphal growth and has 
role in epithelial 
adherence 
C)   Mitochondrial-
associated 
 
1175.88 
 
 
1295.87 
64000 
 s.d. 
3900 
 
66000 
s.d. 
1100 
22000  
s.d. 
 1100 
 
19000 
s.d. 
 7000 
K.YMLLTLLtK.L   (2.96) 
 
 
K.LTtLISSIENK.I   (2.96) 
 
YAP-
bd/ALF4/Glomulin 
family * 
Stress response and 
redox homeostasis, 
induced by H2O2 
1297.59 
 
 
18000  
s.d. 
8800 
 
51000  
s.d. 
 5400 
R.NsIttEsVK.A   (2.03) 
Aldehyde 
hydrogenase 
family* 
 
Ooxidoreductase activity, 
acting on the aldehyde or 
oxo groups of donors, 
NAD or NADP as 
acceptor 
1374.01 
16000 
s.d. 
1300 
10000 
s.d. 
 3000 
R.TASGNIIPSSTGAAK.A   (2.86) 
Glyceraldehyde-3-
phosphate 
dehydrogenase 
NAD
+
 phosphorylation 
and cell 
biogenesis/degradation 
4659.96 
15000 
s.d. 
1100 
3200 
s.d. 
 2700 
K.StIVEEIYsNARSHLVQGNKEmGmALFN
ELLAINESIYGK.V   (3.37) 
 
Clustered 
mitochondria 
protein 
Homolog 
Intracellular distribution 
of mitochondria 
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D)   DNA binding 
575.44 
9700 
s.d. 
1000 
28000  
s.d. 
 6200 
K.SLLSR.I   (1.54) 
Telomerase reverse 
transcriptase 
family* 
DNA binding 
804.77 
42000 
s.d. 
22000 
19000 
s.d. 
 3100 
K.QPAVFSR.I   (2.56) 
 
DNA polymerase 
DNA-directed DNA 
polymerase activity 
1284.83 
27000 
s.d. 
9500 
14000 
s.d. 
 2800 
R.VASHsLsTsR.R   (2.67) 
 
Minichromosome 
maintenance 
protein 10 
DNA replication 
1297.59 
18000 
s.d. 
8800 
51000 
s.d.  
5400 
K.NVIPAtItK.V   (1.54) 
 
 
 
K.EFTIGPFKcIK.W   (1.56) 
 
Spt6 
 
 
Transcriptional 
regulatory 
protein family * 
 
Nucleic acid binding 
 
Zn-ion binding & DNA 
binding RNA 
polymerase II 
transcription factor 
activity 
2806.76 
47000 
s.d. 
36000 
30000 
s.d. 
23000 
R.TTPPTVsITGPNPsSSPAsASTNtSK.S   
(3.60) 
Phosphatase  
family* 
Chromosome segregation 
3376.60 
43000 
s.d. 
12000 
32000 
s.d. 
28000 
K.SSPTSsATTTATtSVsISSLSLtMGKPKNS
K.L   (3.15) 
Mediator complex* 
Cofactor to modulate 
transcription 
3331.28 
63000 
s.d. 
1200 
14000 
s.d. 
1400 
K.GFTNTMISHIGFDPTGtsLNQNsTS 
LGsK.S   (3.21) 
 
Minichromosome 
maintenance 
protein 10 
DNA replication 
3498.15 
34000 
s.d. 
8900 
18000 
s.d. 
16000 
K.LGSVLTtRSQLIEYELtTRtIFINCSA 
ALK.I   (3.11) 
Spt6 Nucleic acid binding 
3503.40 
43000 
s.d. 
8300 
31000 
s.d. 
25000 
 
R.EVIIKLSITRtHtPPPDSTtTTTPTTSIEK.T   
(3.57) 
 
Zn finger  
domain * 
Zn ion binding 
 
3939.14 
36000 
s.d. 
24000 
17000 
s.d. 
18000 
VSSYILDGNNSTKLPsPVLtHtTFDSRsDEG
QR   (3.99) 
 
Basic leucine zipper 
domain* 
DNA binding 
transcription factor 
activity 
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4115.51 
51000 
s.d. 
12000 
24000 
s.d. 
17000 
 
R.APQsIQLPPIQsFtKsQAVFPQSVRDSAPA
ANFNR.Y   (3.12) 
 
 
 
K.sStQMSSCtNsVTQTLDRLPKIVSTQQNN
LTPTSK.I   (3.03) 
 
Transcription factor 
and DNA binding 
protein families* 
 
Zn(2)-DNA binding 
domain * 
DNA binding RNA 
polymerase II 
transcription factor 
activity and Zn ion 
binding 
4173.60 
 
 
24000 
s.d.  
1200 
13000 
s.d.  
1200 
K.tVTsINGSPPPLEtAPsSHHNVPIDFIHFK
KESDR.T   (3.12) 
Uncharacterized 
protein 
DNA binding RNA 
polymerase II 
transcription factor 
activity and Zn ion 
binding 
4368.59 
33000 
s.d. 
21000 
7100 
s.d. 
1300 
K.NMQFPPYQVSsHNsSEtSQsIPNTPSITRQ
VESNTR.S   (3.54) 
 
K.tPTTTTTTTTtANGNTSNGNTSNGNsTG
KTATAATATKSNtK   (3.19) 
Transcriptional 
regulatory protein 
LEU3 
 
Transcription 
protein family* 
 
Sequence-specific DNA 
binding RNA polymerase 
II transcription factor 
activity and Zn ion 
binding 
 
4659.96 
15000 
s.d. 
1100 
3200 
s.d. 
 2700 
MKImmIPTHHQtYNINTHQPPQQHQYLPP
PGtSYTSPR.A   (3.12) 
 
 
R.RSVSYSPGPsSIKSQLPHLTSSSTTtssVQ
SPPPPPPSQPPR.G   (3.61) 
Transcription 
factors and DNA 
binding protein* 
 
Zn (2) – DNA 
binding domain* 
DNA binding RNA 
polymerase II 
transcription factor 
activity and Zn ion 
binding 
E)    Protein synthesis 
804.77 
42000 
s.d. 
22000 
19000 
s.d. 
3100 
K.QTSLNDK.C   (2.54) 
 
 
R.VKIDSDK.S   (1.51) 
 
Mannosyltrans- 
ferase family* 
 
Protein transporter 
SEC24 
Protein glycosylation 
 
 
ER to Golgi vesicle-
mediated transport 
1175.88 
64000 
 s.d.  
3900 
22000  
s.d.  
1100 
K.TKQFNDsKK.K   (2.01) 
Vesicle tethering 
protein family* 
Intracellular protein 
transport 
 
1284.83 
27000 
s.d. 
9500 
14000 
s.d.  
2800 
K.tAGsNHNsEK.K   (2.51) 
Ribosomal RNA-
processing protein 
12 
Protein binding 
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4121.03 
31000 
s.d. 
23000 
17000 
s.d. 
7200 
K.FFsDNIANDLAtTTTTTTTTNTGAtSVHP
ILQVDAIK.Y   (3.24) 
CAS/CSE protein 
family* 
 
Intracellular protein 
transport 
4368.59 
33000 
s.d. 
21000 
7100 
± 1300 
K.ESSSTADQPSVVPPQESHKDTVETPKPE
VtEtsVEAtK.E   (3.24) 
 
K.NPTPTPTPTPTPTPNNLAQGVDsSSTLD
VEtTLtGLtRR.I   (3.21) 
 
Translation 
initiation factor 4G 
 
Imidazoleglycerol 
phosphate synthase 
cyclase subunit 
 
Protein biosynthesis 
 
 
Histidine biosynthesis 
 
F)   Signalling 
3503.40 
43000 
s.d. 
8300 
31000 
s.d. 
25000 
K.RSSITtPtPPLTTTHSSNGNGNGNVNVN
VNsK.R   (3.30) 
 
Peroxisome 
transmembrane 
receptor * 
Protein import 
4115.51 
31000 
s.d. 
20000 
17000 
s.d. 
 7200 
K.QSTTNTsTLssTtAASTLATSNNTQPDTY
TSTSTSIR.G   (3.33) 
Pleckstrin 
homology domain * 
Small GTPase mediated 
signal transduction 
4416.51 
29000 
s.d. 
27000 
16000 
s.d. 
1100 
R.QHPDPLSNQsNFNsNTINNYSNYRSsTR
SGLDPsQR.H   (4.12) 
Rho GTPase 
activating 
protein domain* 
Signal transduction 
4659.96 
15000 
s.d. 
1100 
3200 
s.d. 
 2700 
K.DLPIGYILHmINLcPNIVsLNLGNLSLsT
DYEISRSTIHK.Y   (3.68) 
 
K.WNKEKIELDsPLIVSYVSSLCNGGGGGI
ITNsTNSTttNSK   (1.11) 
F-box protein 
COS111 
 
Pentatricopeptide 
repeat (PPR) 
protein family* 
Signal transduction 
 
 
Termination of G-protein 
coupled receptor 
G)    Miscellaneous 
575.44 
9700 
s.d. 
1100 
28000 
s.d. 
 6200 
R.SLNSR.I   (3.15) 
 
ATPase family* 
 
ATP binding 
1284.83 
27000 
s.d. 
9500 
14000 
s.d. 
 2800 
R.NDsDtsLsK.E   (1.66) 
 
R.YtmNEVFK.V   (2.02) 
 
Insulin induced 
protein family* 
 
GYF domain* 
Cholesterol synthesis 
 
1901.71 
7800 
s.d. 
3900 
13000 
s.d. 
2300 
K.NKATssSSStsRDTR.W   (3.19) 
Leucine rich 
repeats* 
Protein-protein 
interactions 
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3331.28 
63000 
s.d. 
1200 
14000 
s.d.  
1400 
ETsQFMGNAESEDLtGNGLLTSTL 
AVLSSIS   (3.15) 
 
 
Orf in C. albicans 
Major Repeat 
Sequence, RB2 
Region 
 
3331.28 
 
 
3376.60 
63000 
s.d. 
1200 
 
43000 
s.d. 
12000 
14000 
s.d.  
1400 
 
33000 
s.d. 
 28000 
K.LSSLGNHGTtTTSSLSSSsSsSIsNNT 
SIAK.I   (3.46) 
 
R.KQQDQNEVAGAAAATTTTAtAtATAAT
NWKPK.N   (3.21) 
CBS domain* 
Sensing of intracellular 
metabolites 
3498.15 
34000 
s.d.  
8900 
18000 
s.d.  
16000 
K.SSsLIKNsTsSNQSsPATSTNTSIVDVPIE
K.S   (3.21) 
 
 
KAFSSsKLTSDSANStNStNsTSMSILGNDK
.D   (3.16) 
WD repeat protein* 
 
 
CDK inhibitor 
PHO81 
Coordination of  multi-
protein complexes 
 
Lipid metabolism 
 
3895.36 
36000 
s.d. 
4100 
26000 
s.d. 
31000 
R.ISRPNGVGGISTSGSSSPTTEFVTPQAsK
sSVDQNKK.R   (3.29) 
 
Ubiquitin 
interacting  
motif* 
Ubiquitin metabolism 
4173.60 
24000  
s.d.  
1200 
13000 
s.d.  
1200 
R.INNNNDKssILsNITTTNTTTGTGTTNTtT
VPSIKTK.R   (4.24) 
 
WD repeat protein* 
 
Coordination of multi-
protein complexes 
 
4421.03 
32000 
s.d. 
19000 
17000 
s.d.  
7200 
R.HLILGYKItVVtDHQSLTsVMTSSSRPEN
NRMIR.W   (3.83) 
Aspartic peptidase 
family* 
Proteolysis 
3939.14 
 
 
4372.57 
36000 
s.d. 
24000 
 
9600 
s,d. 
4600 
17000 
s.d. 
18000 
 
5400 
s.d. 
 1800 
R.NVNGSGStNtNTMtRLDsTTIASSLFCRQ
LYFNLLSK.D   (3.11) 
 
 
R.NNsTVSSTNSLmSNNsDTNtAATAATAA
TSGSTTNNVKR.M   (3.38) 
 
Globin family* 
 
Heme and oxygen 
binding 
4416.15 
29000 
s.d. 
27000 
16000 
s.d. 1100 
R.NGtYSSsStSSSsTSSVSSSSATTANGESL
NSTTHNIQLER.T   (2.89) 
Sec2p* Vesicular transport 
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4659.96 
15000 
s.d. 
1100 
3200 
s.d.  
2700 
K.QNYVDPGQIAIKGLKGFVNLGAtCFMss
ILQtLIHNPLI.K.Y   (3.69) 
 
 
 
K.YDKPmEDTEEIDDVtSISKsINEQID 
DPFsQFNSVTLR.Y   (3.51) 
Ubiquitin carboxyl-
terminal hydrolase 
 
Protein-
serine/threonine 
kinase 
Anti-ubiquitination 
 
 
 
 
ATP binding 
H)   Uncharacterized 
1175.88 
64000 
 s.d.  
4000 
22000  
s.d.  
1100 
K.tImtItIK.I   (2.07) 
  
1297.59 
18000 
s.d. 
8800 
51000 
s.d.  
5400 
R.NNTtVSKGRIK.V   (1.51) 
 
K.KHQtHILNVK.S   (1.60) 
  
3331.28 
63000 
s.d.  
1200 
14000 
s.d.  
1400 
R.IsNIITLNSSLSSSsSsSSSsSSLLLL 
TLK.S   (3.18) 
  
3895.36 
36000 
s.d. 
4100 
26000 
s.d. 
31000 
K.TTPVMGNSStPSTVtANtNtGAYSTSSDT
AAKPTKK.A   (3.14) 
 
  
3939.14 
36000 
s.d. 
24000 
17000 
s.d. 
18000 
K.TTPVMGNSStPSTVtANtNtGAYSTSSDT
AAKPTKK.A   (3.46) 
  
4115.51 
31000 
s.d. 
20000 
17000 
s.d. 
7200 
K.TVCNWQtLGHTDEFEEstQFARGVSDtA
LVGGITK.L   (2.18) 
 
T.CGKSCFINSttANKLIsYNLFQSStEVDSI
GPTGSK.T   (3.86) 
 
K.TTPVMGNSsTPSTVTANTNTGAYSTSs
DtAAKPTKKATK.R   (3.91) 
 
R.ILLLLPLLGVtILTSKSSLESISLNsPSDSI
ALssSK.S   (2.34) 
  
4416.51 
29000 
s.d. 
27000 
16000 
s.d. 
 1100 
K.STSSANIKtKPKPNTATtATTPTAtTATTt
ATTSSIDPTEK.D   (2.59) 
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4421.03 
32000 
s.d. 
19000 
17000 
s.d. 
 7200 
R.LSGtNNPGsGsGsGGGGGGGANNNSLP
GYSVGSSIGRGRGLGR.G   (1.89) 
  
4368.59 
33000 
s.d.  
21000 
7100 
s.d.  
1300 
K.NYNQFKLIELDDSMNTTTTTTTTTTtTtt
TtTSTIGK.F   (3.76) 
 
K.SKsTTIHNQSNIHSEQISINDENNNKStst
STSTDTK.K   (1.32) 
 
  
4372.57 
9600 
s.d. 
4600 
5400 
s.d. 1800 
K.SSGGSSDTKSVWIAtTGSDFASQSNSDS
sStASRNSSSSASR.Q   (2.46) 
 
K.EsEGVWGWsLQCLLLLFTKVNLRscDQ
LLICALVIR.E   (2.99) 
  
4659.96 
15000 
s.d.  
1100 
3200 
s.d.  
2700 
K.VILIGNSMTsRTTsSVRFFSIMLTVSLPIt
NILVsSELSK.V   (3.11) 
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Our original hypothesis was that surface proteins were affected following Hst 5 
treatments. Hence, our results were examined for their presence and functions. Group (B) 
in Table 3.4 listed the proteins found to have either cellular origins or functions 
pertaining to the cell surface. The bud site selection protein BUD4 showed direct surface 
association with functions directly associated with adhesion. With surface proteins, Hst 5 
would affect the ability of C. albicans to adhere; therefore a decrease in ion counts was 
expected. This did indeed occur as the ion counts went from 66000 ± 1100 before 
treatment, to 20000 ± 7000 following treatment. This supported the microscope images 
taken in Section 3.3.  
At first glance, the number of proteins correlated to the cell surface may be discouraging, 
but the chances of moonlighting proteins was probable. The protein glyceraldehyde-3-
phosphate dehydrogenase (GADPH) was discovered to be an anchorless surface protein 
[52]. Anchorless surface proteins are similar to moonlighting proteins, in that they carry 
functions at one cellular location and then are transported to the cell surface of unknown 
function, but differ in that they originate at the cytoplasm. GADPH has been shown to be 
involved in the Krebs cycle within the cytoplasm. But has also participated in the 
colonization, persistence, and invasion of host tissues [53]. This dual functionality 
demonstrates that perhaps the proteins identified may carry multiple roles, where the 
effects at the cell surface still occur.  
Current research has shown that Hst 5 influences C. albicans at the mitochondria through 
energy metabolism, either through reactive oxygen species (ROS) formation, or via ATP 
release [54, 55]. Similar to the work carried out here, Komatsu et al. used MS to measure 
changes in protein expression at the mitochondrial level [56]. By comparing the level of 
expression before and after Hst 5 treatment, they determined that Hst 5 caused the down 
regulation of proteins participating in cellular respiration and adenosine triphosphate 
(ATP) metabolism. Table 3.4 listed any mitochondrial-associated proteins in Group (C). 
For all entries, it was also determined that the general trend of ion counts was decreasing 
following Hst 5. This showed parallel results to Komatsu et al. Surprisingly, relatively 
few proteins were listed. Only two the protein belonging to the aldehyde hydrogenase 
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family and GADPH showed direct correlation to cellular respiration. The YAP-
bd/ALF4/Glomulin, did not show direct involvement to cellular respiration. However, the 
protein family it belonged to proved otherwise. It is involved in a stress response induced 
by hydrogen peroxide. Hydrogen peroxide has been shown to participate in the formation 
of ROS at the mitochondrial level, thereby killing the cells [54]. The YAP-
bd/ALF4/Glomulin family protein may be involved as a defense mechanism against 
hydrogen peroxide and ROS. This could imply that Hst 5 affects the expression of this 
protein, therefore weakening the defense of C. albicans against ROS. Together, this 
would indicate the possibility of Hst 5 affecting cellular respiration.  
Unexpectedly, what was observed for the majority of the proteins was their connection to 
the nucleic acid. These proteins were listed in Group (D) of Table 3.4. They have 
functions relating to acid (DNA) or ribonucleic acid (RNA) binding, transcription and 
regulation. Previous work has discovered that the structure of Hst 5 was determined to 
have two main metal binding motifs, making it a metallopeptide [57]. The motif at the N-
terminal, binds Cu
2+ 
and Ni
2+
, and is known as the ATCUN-motif with the general 
sequence of NH2-X-X-His. The second motif at the C-terminal, binds Zn
2+
, and has the 
general sequence of His-Glu-X-X-His (HEXXH). It has been discovered that peptides 
with these motifs behave as a DNA intercalator, delivering the peptide and metal cofactor 
close enough to the DNA for binding [58]. Long et al. discovered that when the Ni/Cu-
ATCUN peptide complex formed, it had the ability to cleave nucleic acids in the 
presence of co-reactants [59]. The ATCUN motif would bind the minor groove of DNA, 
and the binding of Zn
2+ 
ions at the HEXXH motif will increase the exposure of the side 
chains of basic residues to increase DNA binding. Hst 5 has been shown to bind DNA, 
however the exact roles of the two metal motifs remains unclear.  The presence of both 
motifs and its cationic nature favours the likelihood of its interaction with DNA for a 
nuclease effect. With DNA damage and without DNA replication, the survival of C. 
albicans is low. Many of the Group (D) proteins had DNA and Zn binding, which are key 
participants in the ATCUN complex model. Therefore, based on these results, it may be 
suggested that the nuclease ability of Hst 5 has occurred. 
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At first, it seemed very plausible that Hst 5 as a metallopeptide, had another mechanism 
whereby it only exerted influence at the nucleus. However, what was discovered was that 
the affects at the nucleus were working in conjunction with effects on cellular respiration 
at the mitochondria. Research done by Melino et al. showed specific function of the 
ATCUN motif in oxidative and hydrolytic cleavage, through its nuclease activity [60].  
The presence of the ATCUN motif bound to DNA led to a triple increase in ROS 
production [61]. ROS can lead to organelle damage via DNA damage. Furthermore, it 
was shown that the Cu-ATCUN complex was a necessary prerequisite for the oxidative 
cleavages [62]. The mitochondria has been shown to house a large pool of Cu
2+
 ions [40]. 
This demonstrated that affects at the nucleus, were only side influences, where the true 
processes affected were those pertaining to mitochondria and cellular respiration.   
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Section 4   Concluding Remarks and Future Work 
 
4.1   Conclusions 
 
With the rapid increase in infections caused by C. albicans, new methods in minimizing 
its effects are needed. The peptide known as Hst 5 has been shown to kills cells in vivo, 
however, its mechanism remains unclear due to its complex multistep nature. Research 
has become focused towards Hst 5 affecting cellular respiration at the mitochondria. In 
this work, it was proposed that the adhesion of C. albicans to the oral cavity is crucial for 
virulence. That Hst 5 may be affecting the surface proteins allowing for attachment. By 
using MS and changes in ion counts, changes in protein expression may highlight which 
proteins are affected.   
The adhesion of live cells of C. albicans and treatment with Hst 5 was successful. 
Following this, on-target tryptic digestions were developed to potentially isolate surface 
proteins. In this way, digestions were shorter and can be quickly executed. Both MALDI 
MS and ESI MS/MS showed the ability to detect changes in ion counts, and protein 
expressions. MALDI MS and ESI MS/MS resulted in different m/z peaks, what was 
prominent was that both techniques showed the same biological pathways were affected. 
Both MS results contained proteins associated at the cell surface. This supported the 
original assumption that the developed on-target digestions were able to cleave surface 
proteins. This also suggested that surface proteins and adhesion may one of the many 
ways in which Hst 5 controls C. albicans. Additionally, what was seen for the majority of 
the remaining tentatively identified protein was their association with the nucleus. Dr. 
Siqueira's previous work showed that the mitochondria was where Hst 5 exhibits its 
therapeutic effects. The presence of these nucleus-associated proteins suggests that Hst 5 
behaves like a metallopeptide. The binding of Hst 5 to DNA has been linked to produce 
ROS. The presence of this species supports that cellular respiration was likely the 
biological process that was affected. 
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4.2   Future Work 
 
In hopes of still exploring the influence of Hst 5 on surface proteins, the determination of 
where the resulting peptides come from may be more sufficient. Indirectly, this can be 
done through the use of immobilized trypsin. Trypsin can be immobilized on beads of 
various materials such as glass or metal. With trypsin immobilized, the chances of 
diffusion into the cell would be minimized. This would have the potential to then limit 
protein cleavage within the cell and subsequently, their incorporation into our MS 
analyses. Therefore, the observed peaks would only correlate to surface proteins.  
A large complication seen with the ion counts, specifically, with the determination of 
whether or not a change was observed. This was mainly because the degree of adhesion 
could not be controlled and so, the number of cells present for each replicate remains 
unknown. To address this, what can be done next is to incubate the slides with the same 
number of cells. This way, variability in ion counts are more controlled and changes 
would be more representative of the effects of Hst 5.  
The tentative identification of proteins has been achieved, however, as the results 
indicated, there were too many possibilities for a single observed m/z ratio. To address 
this, additional replicates could be performed. The proteins identified from these 
additional analyses may highlight which of the already observed proteins are more 
significant. 
Thus far, ESI MS/MS has been applied towards the post-application method of 
introducing Hst 5. The results have identified proteins with changing expressions after 
treatment. MALDI MS results have shown that the same proteins were identified 
independent of when Hst 5 was introduced. The use of ESI MS/MS on pre-application 
slides will be of interest next. The identification from this may result in the same proteins 
as the post-application, provide more proteins, or they may identify a whole different set.  
And lastly, the use of the developed on-target surface digestion can be applied towards 
other microorganisms. By using this approach, it offers a fractionation technique for 
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samples in which peptides may be analyzed. In this way, the sample pool becomes more 
limited, therefore allowing focus on a specific set of proteins.   
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Appendices 
 
Appendix 1: Mass Spectrometry  
 
Mass spectrometry (MS) is an analytical technique capable of correlating measured mass-
to-charge (m/z) ratios of ions generated from samples to their intensities. From acquired 
measurements, a mass spectrum is generated whereby the m/z ratios are plotted along the 
x-axis, and the relative ion intensities on the y-axis. From the spectra, information such as 
masses, isotopic patterns and even structures can be determined. In MS, the sample is 
first introduced into the instrument, whereby it undergoes ionization under high vacuum 
to produce either singly or multiply charged ions. These ions are then accelerated, and it 
is in the mass analyzer, where the ions are separated based on their m/z ratios. As a result, 
the separations allow for ions to reach the detector at different times leading to the mass 
spectrum.  
Small molecules (<500 Da) with a single functional group predominantly give rise to 
singly charged molecules. They can either be [M+H]
+
 in positive mode, or [M-H]
-
 in 
negative mode. Larger molecules containing several functional sites give rise to multiply 
charged ions with a general form of [M+nH]
n+
, such as [M+2H]
2+
. Additionally, adducts 
can also occur with salts such as; [M+Na]
+
, [M+K]
+
, [M+formate]
-
, and [M+acetate]
-
.  
Once ions are produced, they must be separated according to their m/z ratios. This is 
accomplished by mass analyzers. The choice of which mass analyzer is suitable for which 
mass spectrometer depends on factors such as mass range, resolution and sensitivity [63]. 
There are four commonly seen mass analyzers in research today; quadrupole and ion 
traps, time-of-flight (TOF), orbitrap and cyclotron. Focus will be placed on quadrupole 
and ion traps commonly seen with ESI systems, and TOF seen with MALDI systems. 
The quadrupole mass analyzer consists of four oppositely charged, two are positive and 
two are negative, parallel rods in which radiofrequency (RF) and direct current (DC) can 
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be applied [63].
 
 At one end is the ion source, with the detector at the other. When only 
RF is applied, all masses are able to pass through. And when only DC is applied, all 
masses are neutralized by coming into contact with the charged rods. When using a 
combination of RF and DC, ions of certain masses are able to pass through and reach the 
detector, therefore acting as a mass filter. Additionally, ions can become trapped within 
the quadrupole to function as an ion trap. There are two types, linear and nonlinear, 
where emphasis will be placed on linear ion traps. In a linear ion trap, both ends of the 
quadrupole are set to carry the same charge as the ion that one wishes to trap. The 
entrance will be set at a lower voltage than the exit. Damping gas will then be introduced, 
causing ions to lose kinetic energy. As a consequence, ions cannot pass through and 
become trapped. The quadrupole carries its own advantages; it has a low cost, allows for 
easy automation and is physically small in size. 
TOF analyzers, commonly seen with MALDI mass spectrometers, are well suited for 
pulsed ion sources [64]. In TOF analyzers, ions are accelerated into a drift region of 
known length. Lower masses travel down the tube in shorter times due to faster speeds. 
In comparison, heavier masses take longer to travel due to slower speeds. These 
analyzers can operate in two modes, linear and reflectron. In linear mode, ions simply 
travel down the flight tube until they reach the detector. Ions with the same mass will 
have different potential energies, reaching the detector at different times. Consequently, 
this causes a dispersion effect leading to low resolution. To correct for this occurrence, a 
reflector, which will causes ions to reverse directions, can be used in the reflectron mode. 
In this mode, ions with higher kinetic energies penetrate the reflector more deeply, 
reaching the detector later. Ions with lower kinetic energies do not penetrate as much and 
so will reach the detector early. By operating in the reflectron mode, dispersion is 
minimized leading to improved resolution.  
The initial ions produced, known as the precursor ions, can undergo a second 
fragmentation in what is known as tandem MS (MS/MS). In MS/MS, precursor ions from 
the first ionization are chosen and undergo fragmentation. The second fragmentation can 
be done in two ways, collision-induced dissociation (CID) and post source decay (PSD). 
In CID, fragmentation is accomplished by colliding the excited precursor ions with an 
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inert gas such as nitrogen, helium or argon [65]. As a result, the precursor ions become 
unstable and will decompose into the fragment ions. MS/MS spectra will give m/z ratios 
and intensities for all fragment ions of single precursor. By operating CID at lower 
energies, fragmentation occurs at the amide bond between amino acids, instead of at the 
side chain groups [66].  In PSD, fragmentation is accomplished by the laser. The 
precursor ion is selected using an ion gate, where it then travels to a field free region for 
fragmentation [67]. In both cases, the resulting spectra allows for the amino acid 
sequences of peptides to be determined. 
Many types of ionization techniques exist today; where they can are categorized as 
“hard” or “soft”, depending on their ability to keep the analyte molecules intact during 
ionization. “Hard” ionization fragments analytes into their daughter ions which can 
provide structural information. One “hard” ionization technique commonly used is 
electron ionization (EI). In this, an electron beam is based through the gas-phased sample, 
whereby molecules collide with the neutral analyte to give fragmented ions. An 
application of this would be to study the structures of organic and inorganic molecules. 
However, with a developing interest in studying whole intact molecules, “hard” 
ionization was incapable of doing so. As such, with the development of “soft” ionization 
where little fragmentation occurs, molecules remain intact. This then allows for ions to be 
generated from large, non-volatile compounds. Overall this makes the analyses of 
biological compounds such as polysaccharides, drug metabolites and proteins possible. 
Today, there are two “soft” ionization methods, electrospray ionization (ESI) and matrix-
assisted laser desorption ionization (MALDI), widely used in scientific fields. Both will 
be discussed in greater details in section below. 
 
A.1.1   Electrospray Ionization (ESI) 
 
Since 1968, ESI has been incorporated largely into analyzing biomolecules. Figure A.1 is 
a schematic describing the process of ionization. To start, a dilute polar solution 
containing the analyte first flows through a hypodermic needle at a low flow rate [68]. 
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This needle will charge the surface of liquid passing through, where Coulombic forces 
disperse it into charged droplets. As the droplets drift towards the end of the chamber, 
evaporation of the surrounding solvent occurs, thereby decreasing its diameter. As a 
consequence, the charge density on the surface will increase until it reaches its Rayleigh 
limit. Once this limit occurs, a Coulombic explosion occurs were daughter droplets are 
produced. This process of solvent evaporation and explosion repeats until the magnetic 
field is strong enough to desorb ions. The resulting charged droplets are then suitable for 
mass spectral analyses. The ions produced in ESI carry multiple charges with the general 
formula of [M+nH]
n
 in positive mode, and [M-nH]
n
 in negative mode. This multiple 
charging allows for analysis or proteins and peptides with limited m/z range analyzers. 
For small molecules (< 2000 Da) such as peptides; singly, doubly or triply charged ions 
are common seen. For large molecules (> 2000 Da) such as proteins, series of multiply 
charged ions are observed.  
 
Figure A.1. Schematic for electrospray ionization (ESI). The sample-containing solution 
exits the charged needle as an aerosol. Upon desolvation, the aerosol diminishes in size 
until a Coulombic explosion occurs, producing daughter ions which move towards the 
inlet of the mass spectrometer. 
 
With the development of ESI, studying large biomolecules became an area of interest. 
However, along with these analytes, came their complex cellular mixtures. Because of 
this complexity, spectra became too difficult to interpret. As a result, this led to a need for 
chromatographic separations. With the coupling of liquid chromatography (LC) and ESI, 
giving LC-ESI, a continuous stream of liquid sample can be directly introduced into the 
mass spectrometer. Individually, LC is described below followed by a detailed 
explanation of LC-ESI-MS as a hyphenated technique.  
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To start, the sample mixture first undergoes analytical separation by LC. In LC, the 
partitioning of analyte molecules is based on physical factors such as their solubility in 
water and organic solvents, net charge and size [69]. In particular, separations are 
accomplished by using the varying affinities of compounds towards two phases, either 
the mobile or stationary phase. The mobile phase is a solution mixture containing the 
analyte. This is injected into the column and continuously flows throughout. In contrast, 
the stationary phase consists of porous beads, packed and held within the separating 
column. As the components elute off the column, their signals are detected using UV, 
fluorescence or electrical conductivity. The resulting measurements are presented as a 
chromatogram, which plots the signal response of the components against their retention 
times. With the combination of retention times, peak intensities and peak areas, 
components can be successfully identified. In 1970, a variation of LC known as high 
performance liquid chromatography (HPLC) was developed. In HPLC, high pressure is 
used to generate the flow needed for the solution to pass through the column. Today, 
HPLC is one of the most commonly used chromatographic techniques used. In LC, the 
mobile phase moves along the column with very little pressure. However, HPLC differs 
as it uses much high pressures to generate the flow rate of the mobile phase.  
Within LC, there are two types known as normal phase liquid chromatography (NPLC) 
and reverse phase liquid chromatography (RPLC). They are differentiated by the type of 
mobile and stationary phases used. In NPLC, the stationary phase commonly used is 
silica or organic materials with functionalities like cyano or amino groups. Because of 
these, the stationary phase is a polar phase. The mobile phase will then be nonpolar, 
where water and organic solvents are common. As the molecules partition between the 
two phases, the order of elution will be least polar molecules first, and the more polar 
ones later on. In order to elute the polar compounds, solvents of increasing polarity are 
used. In RPLC, the stationary phase is composed of hydrocarbons such as C18, making it 
nonpolar . As for the mobile phase, it is typically a mixture of water and organic solvents. 
Therefore, from this alone, one can see that this type of chromatography has been termed 
“reverse” as it is the opposite of NPLC. The order of elution is thus, from highly polar 
compounds to nonpolar ones. For nonpolar compounds, solvents of higher 
hydrophobicity will be needed to elute compounds from the column. 
72 
 
By using LC alone, separation of mixtures can be done via the competition of the mobile 
or stationary phases for analytes. However, a significant problem that may arise is when 
components elute at very similar retention times. This leads to overlap of peaks and 
identification is not as accurate. By introducing MS as the detector, mass spectra will 
supplement the chromatographic separations. In a LC-ESI-MS setup, as separations elute 
off the column, they undergo the “soft” ionization next. This can be achieved in either the 
online or offline modes. In online, the elution of compounds and ionization are 
continuous. In offline, eluted fractions are collected first and then introduced into the 
mass spectrometer. Of these two modes, online continuous ionization is preferred. In this 
mode, a metal capillary is used instead of the hypodermic needle described previously. 
The sample solution is pumped through the HPLC inlet and nebulized at the end to form 
the spray. The resulting ionic species will then enter a capillary that carries them into the 
high vacuum for mass spectral analyses. Overall, this will provide sufficient information 
where masses and structures from MS, will complement the observed retention times of 
LC.  
 
A.1.2   Matrix-assisted Laser Desorption Ionization (MALDI)  
 
The term “matrix-assisted” laser desorption was first introduced by Karas and colleagues 
in 1985 [70]. In their work, a 1:1 ratio mixture of the amino acids alanine and tryptophan 
underwent ionization and mass spectrometry at a wavelength at 266 nm. At this 
wavelength, alanine was incapable of ionizing. However, when they analyzed the 
mixture, a strong signal was observed for both alanine and tryptophan. Because of this 
observation, they proposed that tryptophan acted as an absorbing matrix which aided ion 
formation of alanine. It was not until 1989 where laser desorption ionization of large 
intact molecules was possible. Tanaka et al. developed the concept of MALDI that is 
used in research today [71]. In their research, the new sample preparation called 
“ultrafine metal plus liquid matrix method” was developed. By combining the use of a 
conductive metal and the “matrix-assisted” laser desorption discovered by Karas, they 
were able to ionize an organic compound up to 34 kDa.
 
Tanaka and his colleagues were 
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able to demonstrate the capability of MALDI for ionizing large molecules, in particular, 
biomolecules. In research today, the concepts of MALDI discovered by Karas and 
Tanaka remain the same. Both a conductive metal plate and a matrix are used to aid in 
ionization.  
One large difference between MALDI in the past and present is the matrices being used. 
As a matrix, the compound must absorb light in the UV region. As such, matrices must 
absorb at the same wavelength as the laser being used. Consequently, in the past, only 
molecules carrying aromatic residues were analyzed using MALDI [72]. Because not 
many aromatic residues may be present, it was clear that the need for a compound to aid 
ionization was necessary. Therefore, due to this lack of one, matrices were developed. 
The theory behind developing matrices was to turn non-ultraviolet (UV) absorbing 
molecules to ones that could. To qualify as a matrix, the compound must be relatively 
water-soluble, not too volatile to prevent rapid evaporation, and it must not be too  
Figure A.2. The schematic for matrix-assisted laser desorption ionization (MALDI). 
Here, the analyte is mixed with a matrix in a 1:1 ratio and spotted onto the target. Upon 
air-drying, crystallization occurs between matrix and analyte. A laser is used to desorb 
these molecules, producing singly-charged ions that can be introduced into the mass 
spectrometer. 
 
chemically reactive [72]. Following these requirements, there are three matrices 
commonly used today; α-cyano-4-hydroxycinnamic acid (CHCA), 2.5-
dihyroxybenzenoic acid (DHB) and sinapinic acid (SA). They can be divided into two 
74 
 
categories; derivatives of cinnamic acid which include CHCA and SA, and derivatives of 
aromatic compounds where DHB lies. Matrices contain functional groups such as –OH, –
SH or –NH, which can supply the proton needed for protonation [73]. 
In MALDI, analytes are dissolved in a solution containing excess matrix, where typically 
a 1:1 volume-to-volume ratio is used. The amount of matrix must be excessive enough to 
completely solvate the analyte.
 
This sample-matrix mixture is then spotted onto a MALDI 
target, typically a conductive metal plate, where the spots are allowed to air-dry. Upon 
drying, crystallization between the analyte and matrix occurs. Once dried, the target can 
be introduced into the mass spectrometer. During ionization, as shown in Figure A.2, a 
laser beam will hit the spots where absorption of light by the matrix occurs. Two 
common lasers are seen today; the first is nitrogen laser with a wavelength of 337 nm, 
and second the neodymeium-doped yttrium nitrogen aluminum garnet (Nd:YAG). 
Nd:YAG comes in two types, frequency tripled which absorbs at 355 nm and quadrupled 
at 266 nm [74]. The energy absorbed is transferred to the analyte, causing it to desorb 
from the target plate.
 
This creates a plume of ions which can be accelerated towards the 
detector. In comparison to ESI, MALDI predominantly produces singly charged ions of 
the general formula [M+H]
+ 
and
 
[M-H]
-
, independent of the mass. The ions will carry 
different m/z ratios, therefore reaching the detector at different times to produce a mass 
spectrum.  
 
A.1.3   Comparison between ESI and MALDI 
 
Both ESI and MALDI are “soft” ionization techniques allowing ionization of whole 
biomolecules. As discussed, the methods of ionization vary drastically. Each carries its 
own advantages and disadvantages. One of the major differences between ESI and 
MALDI is the ability to couple ESI with LC. MALDI, unfortunately, does not possess the 
capacity and is called an offline method. A second difference is that MALDI has a higher 
tolerance towards salts, whereas ESI cannot have samples that contain too many. When a 
sample has a higher concentration of salts, then MALDI may be the better choice.  Lastly, 
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both differ in the types of ions formed. ESI has the capacity to form multiply charged 
ions, and because of this, is said to have an unlimited m/z range [74]. Analytes with 
larger mass can simply appear as lower m/z peaks carrying multiple charges. The 
production of multiply charged ions allows for the production of a larger number of 
daughter ions in MS/MS. For instance, if the multiply charged ion is [M+4H]
4+
, then it 
can be expected that a maximum of four daughter ions can be produced. With the 
increase in the number of daughter ions, the greater the chances of confirming the amino 
acid sequence. MALDI, in comparison, predominantly favours the formation of single 
charged ions. Consequently, the MS/MS can only produce a maximum of one daughter 
ion. Therefore, in comparison with ESI, the determination of the amino acid sequences 
may not be as reliable. What is commonly seen in research today is to use LC-ESI-MS 
for complex mixtures and MALDI MS for simpler ones. However, this need not be the 
ultimate deciding factor. Which one should be used depends on what the technique is 
applied towards, and what outcomes are being sought. 
 
A.2   Proteomics  
 
With the successful development of ESI and MALDI, the applications of MS became 
focused on studying biological components. Emphasis was originally placed on studying 
genes, collectively known as the genome; however, a shift towards studying proteins has 
occurred within the past decades. The genome provides information corresponding to the 
expression of proteins. The study of the proteome, that is all proteins expressed by the 
cell at a given time and state, is what is called “proteomics” today. This allows for large-
scale investigations of the genome and cellular functions indirectly at the protein level 
[75]. As such, proteomics is known to be as a post-genomic science [76]. 
In proteomics, the first crucial step is to isolate proteins from complex biological 
mixtures. This alone is extensive and more challenging when compared to the genome. 
Complications arise due to the fact that one gene can easily encode for several proteins 
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differing anywhere from function to location [76]. In addition, the isolation of proteins is 
difficult as a result of complex backgrounds and low abundances. And so, it is because of 
these difficulties that an analytical technique such as mass spectrometry is needed. By 
incorporating MS into the proteomic work flow, numerous types of biological 
information can be explored.  
One widely used application of MS is peptide mass fingerprinting (PMF). In PMF, 
protein mixtures are subjected to site-specific enzymes, which will generate peptides. 
These experimentally-determined peptides are then analyzed using MS. The resulting 
spectra are searched against databases containing theoretical peptides produced from in 
silico digests. Protein sequence databases, such as UniProtKB, are widely available. 
These are libraries that house the genomes, and likewise the proteins they encode, for a 
significant amount of species. Unfortunately, when the genome for a species has not been 
completely identified, the protein database is also incomplete. As a consequence, when 
running experimental data through them, matches may not occur. Of course, this does not 
mean the obtained peptides are irrelevant.  
When PMF does not provide sufficient information for identification, MS/MS can be 
used to determine the amino acid sequences.  Hunt et al. were able to sequence peptides 
from apolipoprotein B [77]. Apolipoprotein B (apoB) is one of the proteins involved in 
lipid metabolism. In their work, apoB was digested with the enzyme trypsin. Trypsin 
cleaves on the C-terminal side of lysine and arginine, except when followed by proline. 
The resulting peptides underwent MS/MS in a triple quadrupole mass spectrometer, 
producing spectra where sequences were determined. The determination of these 
sequences allowed for confirmation of the apoB protein.  
Another common application of MS in proteomics is for the detection of post-
translational modifications of proteins. Once proteins are folded, they may undergo 
further modification before being transported to their cellular location. For instance, 
proteins undergo common modifications such as phosphorylation, the addition of 
phosphate groups, or glycosylation, which is the addition of sugars. The addition of these 
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groups will change the masses of said proteins, which can then be successfully 
determined by MS [78].  
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Appendix 2: Preparation of Media Used  
 
Stock cultures of C. albicans were grown on Sabouraud dextorse agar (SDA) plates. 
They were prepared as following: 
 1. Prepare a 6.50% (m/v) solution in water. Heat with stirring to aid in dissolution 
 2. Autoclave at 121°C for 25 minutes with a 10 minute steam down 
 3. Once cooled to room temperature, sterile polystyrene 100 mm x 15 mm Petri  
     dishes with stackable lids 
 4. The cooled plates are then placed into a 37°C oven overnight to ensure no  
       microbial growth has occurred 
 
Yeast nitrogen base (YNB) broth was use for the cell growth of C. albicans. It can be 
prepared as following: 
 1. Dissolve 6.70 g in 100 mL H2O to make the solution known as 10X YNB 
 2. Dissolve 18.00 g of sucrose in 900 mL H2O. 
 3. Supplement the sucrose solution with 100 mL of 10X YNB to make a final    
     volume of 1.00 L 
 4. Sterilize by autoclaving 
 5. Then filter the final solution 
 
1X phosphate buffered saline (PBS) solution was for washings of cells and preparation of 
adhered slides. It can be made according to the protocol below: : 
 1. Dissolve the four components in 800 mL H2O: 
  8.00 g of sodium chloride (NaCl) 
  0.20 g of potassium chloride (KCl) 
  1.44 g of sodium basic diphosphate (Na2HPO4) 
  0.24 g of monopotassium phosphate (KH2HPO4) 
 2. Bring the pH to 7.4 using hydrochloric acid (HCl) 
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 3. Then bring the final volume to 1.00 L using water 
 4. If necessary, sterilize the media via autoclaving 
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Appendix 3: MALDI MS/MS Raw Spectrum 
 
Once a list of peaks characteristic to C. albicans was determined, tandem mass 
spectrometry (MS/MS) was performed. This second fragmentation would be able to 
provide the specific amino acid sequence of the selected precursor ion. For a majority of 
the peaks, second fragmentation was not possible due to the low ion counts. For an 
adequate spectrum, the precursor ion should have an ion count of 2000. In the cases of 
peaks that did meet this requirement, their spectra suffered significantly from 
contamination and background noise. Figure A.3 is the MS/MS spectrum for the m/z peak 
of around 1677, demonstrating this scenario. The presence of the m/z peak of around 175 
did indicate that this was a peptide, as this corresponds to C-terminal arginine from a 
tryptic digest. However, other than this, sequencing could not be done. The presence of 
this many peaks did not allow for the differentiation between relevant amino acids and 
non-informative background ions. 
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 Figure A.3. MALDI MS/MS spectrum for the precursor ion with m/z = 1677.80.  
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Appendix 4: Bicinchoninic Acid (BCA) Assay for Peptide Quantification 
 
To meet the detection limit of the linear trap quadrupole (LTQ) mass spectrometer, 2 µg 
of peptides were required. When working with peptides, who have molecular masses of 
4000 Da or lower, the bicinchoninic acid (BCA) assay is ideal. The BCA assay relies on 
the generation of a coloured complex between peptide bonds and the Cu
2+
 ion in alkaline 
environments [79]. The concept of the BCA assay stems from the initially used Lowry 
reagent, and today it is substituted as it has a higher salt tolerance. The BCA assay is 
composed of two major reactions; the first is known as the biuert reaction, and the second 
is chelation [79]. The biuret reaction is where an organic compound know as biuret reacts 
with Cu
2+
 to form a light blue coloured complex [80]. This reaction is shown in Figure 
A.4. The major product of this reaction is the Cu
+
 ion, which will be needed in the second 
step of the BCA assay.  
 
 
 
 
 
 
 
 
Figure A.4 The first reaction, known as the biuret reaction, of the BCA assay. This 
reaction reduces Cu
2+ 
to Cu
+ 
through the binding of the amide bond, which will be needed 
for the second half of the BCA assay [79]. 
 
As seen in Figure A.4, a single Cu
2+
 ion has the ability to bind to four to six amide bonds 
[79]. In the second reaction shown in Figure A.5, the BCA reagent is chelated to the Cu
+
, 
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producing the BCA-Cu complex. And it is this complex that allows for indirect 
measurement of protein. Essentially, the amount of complex produced reflects how much 
Cu
+
 is produced, which then ultimately indicates how many amide bonds were present to 
cause the copper reduction. This complex absorbs strongly at a wavelength of 562 nm, 
however measurements can be taken anywhere between 550 to 570 nm.  
 
 
 
 
 
 
 
Figure A.5 The second reaction of the BCA assay. Here, Cu
+
 reacts with the BCA salt. 
The production of the complex corresponds to the amount of protein originally bound to 
the biuret reagent [79]. 
 
To create the standard curve, known concentrations of bovine serum albumin (BSA) were 
used. A total of eight standards were used. The preparation volumes and final 
concentrations are displayed in Table A.1.  
 
 
 
 
 
 
 
+ 
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Table A.1 Standard BSA concentrations and volumes used to determine the standard 
curve in the BCA assay. 
Vial 
Volume of H2O 
(µL) 
Volume OF BSA  
(µL) 
Measured BSA 
Concentration (µg/mL) 
A 400 0 0 
B 325 325 from C 125 
C 325 325 from D 200 
D 325 325 from F 500 
E 175 325 from G 750 
F 325 325 1000 
G 125 325 1500 
H 0 300 2000 
 
The protocol for performing the BCA assay was provided by the manufacturer (Fisher 
Scientific, USA). The buffer in which the peptides are suspended in, in this case 
ammonium bicarbonate, was diluted by a factor of ten. The diluted ammonium 
bicarbonate was then mixed in a 1:1 (v/v) ratio with the BSA standards. 20 µL of this 
mixture was pipetted into sixteen wells, two per concentration, in a 96 microwell plate. 
For the digested peptides, they were diluted by a factor of ten using the diluted 
ammonium bicarbonate. 10 µL of the diluted peptides were then pipetted into two wells 
each, and were further diluted by the addition of 10 µL of water. Overall, this ensures the 
total volume of standards and analytes were consistent. To each well, 180 µL of the BCA 
reagent was added. The microwell plate was incubated at 37°C for 30 minutes. After 30 
minutes, the plate was cooled to room temperature before measurements were taken. 
Readings were taken on 1420 Multilabel Counter Victor
3
V (Perkin Elmer, Canada) at a 
wavelength of 560 nm. The corresponding software used was the Perkin Elmer 2030 
Manager.  
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Appendix 5: ZipTip Protocol 
 
Prior to analyses by HPLC-ESI-MS/MS, our digested peptides underwent sample cleanup 
and concentration. This was accomplished by using 10 µL ZipTip C18.  The protocol used 
between different samples should be optimized. For our purposes, the protocol used in 
our research will be discussed. 
The list of solutions is as follows: 
 - wetting solution: 50% acetonitrile 
 - equilibration and wash solution: 0.1% trifluoroacetic acid 
 - elution solution: 80% acetonitrile 
The protocol consists of five steps, which are described below: 
1. Decontamination of the ZipTip using the wetting solution. This will remove non-
specific peptides. 
a.  Using 40 µL, wet the resin by pipetting and expelling the waste. Perform 
this twice 
2. Equilibration with the equilibration and was solution. This will remove 
acetonitrile  
a.  Using 30 µL, introduce the solvent by pipetting and expelling the waste. 
Repeat this two times 
3. Acidification making the peptides negatively charged to bind the resin.  
a. To acidify peptides, 0.5 µL increments of 0.5% trifluoroacetic acid are 
added. The pH is checked after each addition until a pH of around 4 is 
reached 
b. The acidified peptides are then pipetted up and down ten times 
4. Removal of ions from the ZipTip using the equilibration and wash solution. 
Peptides will remain bound to the resin 
a. Using 20 µL, the solution is pipetted up and down five times 
5. Elution of peptides using the elution solution 
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a. Using 5 µL of the solution, the peptides on the resin are pipetted up and 
down ten times 
b. The solution is kept as it contains the peptides 
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